WO2004029060A1 - 新規除草剤、その使用方法、新規チエノピリミジン誘導体及びその中間体並びにその製造方法 - Google Patents
新規除草剤、その使用方法、新規チエノピリミジン誘導体及びその中間体並びにその製造方法 Download PDFInfo
- Publication number
- WO2004029060A1 WO2004029060A1 PCT/JP2003/012356 JP0312356W WO2004029060A1 WO 2004029060 A1 WO2004029060 A1 WO 2004029060A1 JP 0312356 W JP0312356 W JP 0312356W WO 2004029060 A1 WO2004029060 A1 WO 2004029060A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- alkyl
- halo
- alkoxy
- same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/40—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by doubly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
- C07C69/92—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with etherified hydroxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/36—Nitrogen atoms
Definitions
- the present invention relates to a novel herbicide, a method for using the same, a novel chenobilimidine derivative and an intermediate thereof, and a method for producing the same.
- the present invention relates to a herbicide containing a substituted chenobilimidine derivative as an active ingredient, a method for using the same, a novel compound useful as the herbicide, a method for producing the compound, and an intermediate thereof.
- a stable supply of important crops is indispensable to address the food crisis associated with the world population growth expected in the near future.
- Stable crop supply requires the control of weeds that hinder cultivation and harvesting due to economic and efficiency problems.
- Agent development is becoming increasingly important.
- the present inventors have conducted intensive studies to solve the above problems, and as a result, have found that chenobilimidines having a specific substituent have herbicidal activity, and have completed the present invention.
- R 1 represents a hydrogen atom or an optionally substituted alkyl group
- R 2 represents a hydrogen atom, a halogen atom or an optionally substituted alkyl group.
- Q 1 represents a hydrogen atom, a halogen atom, a cyano group, a hydroxyl group, a carboxy group or ⁇ 1 ! ⁇ 3 (wherein X 1 is a single bond, —O—, —SOn— (where n is 0 to 2 . that of an integer), in -OSO n-(wherein, n is as defined above), single CO-, one C0 2 -. one OC0 2 - indicates or _OC (O) mono-,
- R 3 is an alkyl group which may be substituted, an alkenyl group which may be substituted, an alkynyl group which may be substituted, an amino group which may be substituted, a aryl group which may be substituted or It represents a heterocyclic group which may be substituted. ),
- Q 2 is a hydrogen atom, a halogen atom, a hydroxyl group or —X 2 R 4 (wherein X 2 is a single bond, one O—, —SOn— (where n is the same as above), and one OS On— (Wherein, n is the same as above.),
- X 2 is a single bond, one O—, —SOn— (where n is the same as above), and one OS On— (Wherein, n is the same as above.)
- R 4 is an alkyl group which may be substituted, an alkenyl group which may be substituted, an alkynyl group which may be substituted, an amino group which may be substituted, a aryl group which may be substituted or It may be substituted! /, Indicating a heterocyclic group. ).
- a herbicide comprising, as an active ingredient, a substituted chenopyrimidine derivative represented by the formula: (2) General formula (I)
- R 1 represents a hydrogen atom, ((to ( 6 ) alkyl group or halo (Ci Cj alkyl group
- R 2 represents a hydrogen atom, a halogen atom, a (Ci Ce) alkyl group or a halo (Ci Ce) alkyl group.) Represents a group.
- a 2 represents a hydrogen atom, ((to ( 6 ) alkyl group or halo (Ci Cj alkyl group
- R 2 represents a hydrogen atom, a halogen atom, a (Ci Ce) alkyl group or a halo (Ci Ce) alkyl group.
- Q 1 is a hydrogen atom, a halogen atom, a cyano group, a hydroxyl group, a carboxy group or —XiR 3 (wherein X 1 is a single bond, —O—, -SOn- (where n is an integer of 0 to 2) .), in -OSO n-(wherein, n is as defined above), single CO-, one C0 2 -., shows a _OC0 2 _ or one OC (O) mono-,
- R 3 is a (Ci Cio) alkyl group, a halo (( ⁇ ⁇ . ⁇ .) Alkyl group, a cyclo (C 3 -C 6 ) alkyl group, a halocyclo (C 3 -C 6 ) alkyl group, a (.-. ⁇ Alkoxy
- alkyl group halo (Ci Cj alkoxy (C CJ alkyl group, ((: ⁇ alkyl (C 3 -C 6 ) cycloalkyl group, cyclo (C 3 -C 6 ) alkyl (-) alkyl group, ( C ⁇ C alkoxycarbonyl Interview le ( ⁇ ) alkyl group, (Amino) human Dorokishi (C 2 -C 6) alkyl group, (C a - C 4) alkylthio ( ⁇ ) alkyl le group, (C ⁇ CJ alkylsulfinyl ( C ⁇ CJ alkyl group, ( ⁇ ) Al alkylsulfonyl ( ⁇ ⁇ Ji alkyl group, (C 2 ⁇ C 6) alkenyl group, a halo (C 2 ⁇ C ⁇ C
- alkylsulfonyl group mono ((: to ( 6 ) alkylamino group or di (CiCj alkylamino group having at least one substituent selected from alkylamino groups which may be the same or different) Substituted phenylamino group, aryl group, which may be the same or different, halogen atom, cyano group, nitro group, hydroxyl group, amino group, SH group, (C ⁇ Cs) alkyl group, nitro (CiC alkyl) group, Sik b (C 3 ⁇ C 6) alkyl group, Nono Roshikuro (C 3 ⁇ C 6) alkyl group, (C 2
- Alkylamino cyano group or identical Wakashi Ku is different good di (Ci ⁇ C 6) substitution ⁇ having one or more substituents selected from Arukiruami amino group Re Alkyl group, aryl (Ci Ce) alkyl group, which may be the same or different, halogen atom, cyano group, nitro group, hydroxyl group, amino group, SH group, (C Ce) alkyl group, halo ⁇ alkyl, cycloalkyl (C 3 ⁇ C 6) alkyl group, Haroshiku b (C 3 ⁇ C 6) alkyl, (C 2 ⁇ C 6) alkenyl group, halo (C 2 ⁇ C 6) alkenyl, (C 2 to C 6 ) alkyl group, halo (C 2 to C 6 ) alkyl group, (Ci to C 6 ) alkoxy group, nodro (Ci to C 6 ) alkoxy group, cyclo (C 3 to C 6) )
- alkylsulfonyl group mono (( ⁇ to. ⁇ Alkylamino group or a substituted aryl having at least one substituent selected from the same or different di (CiCj alkylamino group) on the ring ( Alkyl groups, heterocyclic groups (heterocycles are oxosilane, oxetane, tetrahydrofuran, furan, thiophene, pyrrole, pyrrolidine, oxazole, oxazoline, oxazolidin, thiazole, thiazoline, thiazolidine, imidazole, imidazoline, imidazoline, triazole).
- heterocyclic groups heterocyclic groups (heterocycles are oxosilane, oxetane, tetrahydrofuran, furan, thiophene, pyrrole, pyrrolidine, oxazole, oxazoline, oxazolid
- the alkyl group (the heterocyclic ring may be the same as described above) or the same or different; a halogen atom, a cyano group, a nitro group, a (Ci-C 6 ) alkyl group, a halo (C Ce) alkyl group, a cyclo (C 3
- Q 2 represents a hydrogen atom, a halogen atom, a hydroxyl group, or —X 2 R 4 (wherein X 2 is a single bond, one O—, -SOn- (where n is the same as above), -OSOn- (formula Wherein n is the same as above.), One CO—, one co 2 _, one oco 2 — or one OC (O) —
- R 4 is (Ci C o) alkyl group, halo (. ⁇ ..) Alkyl, cyclo (C 3 - C 6) alkyl groups, halo (C 3 -C 6) cycloalkyl group, (Ci Cj alkoxy
- Alkylamino group phenylamino group, which may be the same or different, which may be the same or different, halogen atom, cyano group, and nitrogen group, hydroxyl group, amino group, SH group, (Ci Ce) alkyl group, halo (Ci ⁇ C 6) alkyl group, cyclo (C 3 ⁇ C 6) alkyl group, Nono Roshikuro (C 3 -C 6 ) Alkyl group,
- alkylsulfonyl groups mono (Ci ⁇ C 6) alkylamino cyano group or the Ichiwaka substituted ⁇ Li properly is having one or more substituents selected from a good different di ( ⁇ ⁇ Ji ⁇ alkylamino cyano group Alkyl group, aryl group (Ci Cj alkyl group, which may be the same or different, halogen atom, cyano group, nitro group, hydroxyl group, amino group, SH group, (dialkyl group, nitro group) alkyl group, consequent b (C 3 ⁇ C 6) alkyl group, Nono b consequent b (C 3 ⁇ (: 6) alkyl, (C 2 ⁇ C 6) Aruke - group, halo (C 2 ⁇ C 6) Alkenyl group, (C 2 -C 6 ) alkynyl group, halo (C 2 -C 6 ) alkynyl group, (j-j ⁇ alk
- a heterocyclic ring (Ci Cj alkyl group (the heterocyclic ring is the same as described above)) or may be the same or different, and may be a halogen atom, a cyano group, a nitro group, a (Ci Ce) alkyl group, Halo 6) alkyl group, a cycloalkyl (C 3 -C 6) Arukinore group, Nono Roshikuro (C 3 ⁇
- a herbicide comprising a substituted chenopyrimidine derivative as an active ingredient.
- Q 1 is —OR 3 ⁇ wherein, R 3 is a (( ⁇ to (:) alkyl group, a halo (C i C) alkyl group, a cyclo (C 3 to C 6 ) alkyl group, ⁇ Alkoxy 6 ) alkyl group, halo (Ci Cj alkoxy (Ci Cj alkyl group, (( ⁇ ⁇ .) Alkyl group (C 3- C 6 ) alkyl group, cyclo (C 3- C 6 ) alkyl (C ⁇ CJ alkyl group, (C ⁇ CJ alkoxycarbonyl ( ⁇ ) alkyl group, (Amino) human Dorokishi (c 2 to c 6) alkyl group, (c ⁇ cj alkylthio (Ji ⁇ .
- alkyl group (( ⁇ ⁇ Ji alkylsulfinyl ( ( ⁇ ⁇ Ji ⁇ alkyl group, (c 1 to c 4) alkyl Rusuruhoniru (c to c 4) alkyl group, (c 2 to c 6) alkenyl, halo (c 2 to c 6) alkenyl group, human Dorokishi (c 2 ⁇ c 6) alkenyl group, human Dorokishiha port (c 2 ⁇ c 6) alkenyl, phenyl (c 2 ⁇ c 6) alkenyl group, (c 2 to c 6 ) alkynyl group, halo (c 2 -c 6 ) alkyl group, amino group, mono (C CJ alkylamino group, monohalo (Ci Cj alkylamino group, same or different) .
- alkylamino group the same or different and may dihalo (Ci ⁇ c 6) alkylamino group, Fueniruamino group, which may be identical or different, halo gen atom, Shiano group, a nitro group, a hydroxyl group, an amino group, SH group, (Ji-Ji ⁇ alkyl group, Nono b (Ji ⁇ .
- alkylthio group halo (di-. Alkylthio group, (di-. ⁇ Alkylsulfinyl group, nodro (c 1 -c 6 ) alkylsulfuryl group, (Ci Cj alkylsulfol group, Substituted ring having at least one substituent selected from a halo (C 6 -C 6 ) alkylsulfonyl group, a mono (C 1 -C 6 alkylamino group) and a di (C i Cj alkylamino group which may be the same or different).
- Nylamino group aryl group, which may be the same or different, halogen atom, cyano group, nitro group, hydroxyl group, amino group, SH group, (d Cj alkyl group, halo (c cj alkyl group, (c 2 to c 6 ) Alkenyl group, nodro (c 2 -c 6 ) alkenyl group, (C 2 -C 6 ) alkyl group, halo (C 2 -C 6 ) alkynyl group, (C i Cj alkoxy group, halo (C CJ Alkoxy group, (C Cj alk Ruthio group, Ci Ce) alkylthio group, C Ce) alkylsulfinyl group, peroxy (.-alkylsulfinyl group, ⁇ alkynolesulfonyl group, halanolokesulfoninole group, mono (.- alkylamino group or the same) A substituted C
- (Ci-Ce) an alkyl group, which may be the same or different, a halogen atom, a cyano group, a nitro group, a hydroxyl group, an amino group, an SH group, a ( ⁇ ⁇ (: 6 ) alkyl group, a halo
- Alkylamino group or di (C Ce) which may be the same or different Substituted aryl having one or more substituents selected from alkylamino groups on the ring (Ci Cj alkyl group, heterocyclic group (heterocyclic is oxysilane, oxetane, tetrahydrofuran, furan, thiocyanphen, pyrrole, pyrrolidine) , Oxazole, Oxazoline, O Xazolidine, thiazole, thiazoline, thiazolidine, imidazole, imidazoline, imidazolidine, triazole, triazolidine, isoxazole, isoxazoline, isotiazole, isotiziazolidine, virazole, vilazoline, virazolidine, pyridrazine, pyridrazine, pyridrazine shows Ji Omoruhorin, piperidines Rajin, piperidine or Okisajin
- Q 2 is a (C Cio) alkyl group, a cyclo (C 3 -C 6 ) alkyl group,
- alkylthio group cyclo (C 3 -C 6 ) alkylthio group, (Ci Ce) alkylsulfyl group, cyclo (C 3 -C 6 ) alkylsulfyl group, ( ⁇ - ⁇ alkyls Ruphonyl group, cyclo (c 3 -c 6 ) alkylsulfonyl group, heterocyclic group Thiazolidine, imidazonole, imidazoline, imidazolidin, triazole, triazolidine, isoxazole, isoxazoline, isothiazole, isothiazolidine, virazole, pyrazoline, pyrazolidine, tetrazole, tetrahydropyran, pyrididine, pyrimidine, pyrimidine, pyrimidine, pyridine Azine, piperidine or oxazine), which may be the same or different, and include a fluorinated (Ci Ce) alkyl
- (C 1 -C 6 ) alkylsulfinyl group Noguchi (C ⁇ CJ alkylsnolebuininole group, cyclo (C 3 -C 6 ) anorekylsulfinyl group, nodrocyclo (C 3 -C 6 ) alkylsulfinyl group , (Ci-C 6 ) alkylsulfonyl, halo (C 1 -C 6 ) alkylsulfonyl, cyclo (C 3 -C 6 ) alkylsulfonyl, or halocyclo (C 3 -C 6 ) alkylsulfonyl
- the herbicide according to any one of (1) to (3), which may have one or more substituents.
- Q 1 is a hydrogen atom, a halogen thickener, a cyano group, a hydroxyl group, a carboxy group, a (Ci-C 10 ) alkyl group, a halo (Ci-C 6 ) alkyl group, a (Ci-C 6 ) alkoxy (Ci-C 6 ) Alkyl group, halo (Ci Cj alkoxy (Ci Cj alkyl group, (Ji-Ji ⁇ .) Ryo alkoxy group, halo (Ji-Ji alkoxy, cyclo (c 3 to c 6) alkoxy group, Nono Roshikuro (C 3 - C 6 ) alkoxy group, (C ⁇ CJ alkoxy (c ⁇ cj alkoxy group, halo (C ⁇ Ce) alkoxy (C ⁇ CJ alkoxy group, ( ⁇ ) alkoxycarbonyl (C ⁇ Cs) alkoxy group, (amino)
- alkoxy group the same or different and may di (Ci Cj alkylamino (C ⁇ c 3) alkoxy groups, (c 2 ⁇ c 6) alkenyl, halo (c 2 ⁇ c 6) alkenyl group (C 2 -C 6 ) alkenyl group, (C 2 -C 6 ) alkyl Keniruokishi group, halo (C 2 ⁇ C 6) Arukeniruokishi group, (C 2 ⁇ C 6) Arukiniruokishi group, an amino group, a mono (C ⁇ .
- Alkylamino group the same or different and may di (Ci Cj alkyl amino group, the same or different and may be 1 or more halo (Ci C alkyl-substituted substituted phenyl group with a group, pyrrolyl group, imidazolyl group, the same or different and may one or more (Ci to c 3) alkyl substituted substitution imidazolyl group group, may pyrazolyl group, the same or different dates, is selected from 3) alkyl or halo (Ci ⁇ C 3) alkyl group
- alkylsulfonyl O alkoxy group phenylpropyl sulfonyl O alkoxy group
- Q 2 is a halogen atom, a hydroxyl group, (Ci C alkyl group, a halo (Ci Cj alkyl group, cyclo (C 3 -C 6) alkyl group, Haroshikuro (C 3 -C 6) alkyl group, (. ⁇ .
- a method for using a herbicide which comprises subjecting an effective amount of the herbicide according to any one of (1) to (5) to soil treatment, foliage treatment or flooding treatment.
- R 1 represents a hydrogen atom, a (Ci Cs) alkyl group or a halo (Ci Cj alkyl group
- R 2 represents a hydrogen atom, a halogen atom, a (Ci-C 6 ) alkyl group or a halo (Ci Cj alkyl) Represents a group.
- Q 1 represents a hydrogen atom, a halogen atom, a cyano group, a hydroxyl group, a carboxy group or —— 1 ! ⁇ 3 (formula In the formula, X 1 is a single bond, —O—, —SOn— (wherein n is an integer of 0 to 2), —OSO n— (where n is the same as above), and one CO— , One C0 2 _, one OC0 2 — or one OC (O)
- R 3 is a (Ci Cio) alkyl group, a halo (CCo) alkyl group, a cyclo (C 3 -C 6 ) alkyl group, a halocyclo (C 3 -C 6 ) alkyl group, (. ⁇ ⁇ Alkoxy
- alkyl group halo (Ci Ce) alkyl, cycloalkyl (C 3 -C 6) alkyl group, halocycloalkyl (C 3 -C 6) alkyl group, (C 2 -C 6) alkenyl group, halo (Ci Ce) alkyl, cycloalkyl (C 3 -C 6) alkyl group, halocycloalkyl (C 3 -C 6) alkyl group, (C 2 -C 6) alkenyl group, halo (Ci Ce) alkyl, cycloalkyl (C 3 -C 6) alkyl group, halocycloalkyl (C 3 -C 6) alkyl group, (C 2 -C 6) alkenyl group, halo (Ci Ce) alkyl, cycloalkyl (C 3 -C 6) alkyl group, halocycloalkyl (C 3 -C 6) alkyl group,
- 3- to 6- substituted alkylsulfonyl groups mono (di- to di- 6 ) alkylamino groups or di (CiCj alkylamino groups) which may be the same or different, having at least one substituent on the ring
- Alkylamino cyano group or identical Wakashi Ku is substituted ⁇ rie having 1 or more substituents selected from differently good di (Ci ⁇ C 6) alkylamino cyano group Alkyl group, aryl (CiC alkyl group, which may be the same or different, halogen atom, cyano group, nitro group, hydroxyl group, amino group, SH group, (CiCj alkyl group, nodro (CiCj alkyl group, cyclo (C 3 ⁇ C e) alkyl group, halo consequent b (C 3 ⁇ (6) alkyl group, (C 2 -C 6) alkenyl group, Nono b (C 2
- ⁇ . ⁇ Alkylcarbonyl One or more substituents selected from an alkoxy group, a (Ci Cj alkoxy group, a halo (. To ⁇ ⁇ alkoxy group, a cyclo (C 3 -C 6 ) alkoxy group or a halocyclo (C 3 -C 6 ) alkoxy group)
- Q 2 represents a hydrogen atom, a halogen atom, a hydroxyl group or —X 2 R 4 (wherein X 2 is a single bond, one O—, -SOn- (where n is the same as above), -OSOn- (formula Where n is the same as above.), One CO—, _co 2 _, _oco 2 — or one OC (O) —
- R 4 is ⁇ ) alkyl group, halo (( ⁇ - Ji) alkyl, cyclo (C 3 -C 6) alkyl group, halo (C 3 -C 6) cycloalkyl group, (C Cj alkoxy ( ⁇ . 6) alkyl group, ⁇ b ( ⁇ ) alkoxy (C ⁇ C alkyl group, ( ⁇ Ji Arukirushiku port (C 3 -C 6) alkyl, cycloalkyl (C 3 -C 6) alkyl (C ⁇ CJ-alkyl group, (( ⁇ ⁇ (: Alkoxycarbonyl alkyl group, (C ⁇ CJ alkylthio (C ⁇ CJ alkyl group, (C! ⁇ C 4 ) alkylsulfiel (Ci ⁇ C
- alkyl group (c 1 to c 4) alkylsulfonyl ( ⁇ ) alkyl group, (c 2 to c beta) alkenyl, halo (c 2 to c 6) alkenyl group, human Dorokishi (c 2 to c 6) an alkenyl group, human Dorokishiha port (c 2 ⁇ c 6) alkenyl, phenyl (c 2 ⁇ c 6) alkenyl group, (c 2 ⁇ c 6) alkynyl, halo (c 2 ⁇ c 6) alkynyl group, Ami amino group, mono (Ci ⁇ C 6) alkylamino amino group, monohalo (Ci ⁇ C 6) alkylamino group, the same or different and may di (Ci ⁇ C 6) alkylamino group, the same or different and may dihalo ( Ci Cj alkylamino group, phenylamino group, which may be the same or different, halogen atom, cyan
- alkyl Sulfonyl group cyclo (C 3 -C 6 ) alkylsulfonyl group, nodrocyclo (c 3 -c 6 ) alkylsulfonyl group, mono (Ci Cj alkylamino group or di (Ci-C 6 6 ) a substituted phenylamino group having at least one substituent selected from an alkylamino group on the ring, an aryl group, which may be the same or different, a halogen atom, a cyano group, a nitro group, a hydroxyl group, an amino group, an SH group, (Ci Cj A Kill group, halo (C ⁇ CJ alkyl group, consequent b (C 3 -C 6) alkyl group, Nono Roshiku b (c 3 to c 6) alkyl group, (c 2 to c 6) Aruke - Honoré groups, halo ( c 2 to c 6) alken
- alkyl sulfide El group a halo (Ci Ce) ⁇ Roh gravel Rusuru sulfinyl group, consequent Russia (C 3 to C 6 ) alkylsulfuryl groups, chlorocyclo (C 3 to C 6 ) alkynolenorefinyl groups, E - group, Nono b (c 1 ⁇ c 6) ⁇ Honoré keno less Honoré E group, cyclo (c 3 ⁇ c 6) ⁇ Rukirusuruho - group, Haroshikuro (c 3 ⁇ c 6) alkylsulfonyl group, model No (Ci Cj alkylamino group or diamine which may be the same or different
- a substituted aryl having at least one substituent selected from an alkylamino group on the ring (the same as above).
- An alkyl group, a heterocyclic group (the heterocyclic ring is the same as described above), and may be the same or different.
- halogen atom Shiano group, a nitro group, (Ci Cj alkyl group, halo (C ⁇ Arukinore group, cyclo (C 3 ⁇ C 6) alkyl group, Haroshikuro (C 3 ⁇ C 6) Al kill group, ⁇ alkylcarbonyl O
- a substituted heterocyclic ring having one or more substituents selected from an alkoxy group on the ring (Ci Cj alkyl group (the heterocyclic ring is the same as described above)); .
- A is A1
- Q 1 is —OR 3 (where R 3 is the same as (7))
- Q 2 is a hydrogen atom, a halogen atom, a hydroxyl group or _X 2 R 4 (wherein X 2 is the same as in (7), and R 4 is (C to J.) alkyl, halo (Ci-CJ alkyl, cyclo (C 3 -C 6 ) alkyl, (C ⁇ CJ alkoxy (Ci Cj alkyl) groups, halo (Ci ⁇ C 6) an alkoxy 6) alkyl group, (Ci Cj alkyl cyclo (C 3 -C 6) alkyl, cycloalkyl (C 3 -C 6) alkyl (Ci Cj alkyl group, (Ci C alkoxy Cal Boniru (Ci C alkyl group, (Ci Cj alkylthio (Ci Cj alkyl group, ⁇ Ji alkyl sul
- a substituted phenylamino group which may be the same or different, and having a fluorine-containing (C CJ alkyl group, a fluorine-containing (( ⁇ to ( 6 ) alkoxy group or a fluorine-containing (Ci Cj alkylthio group selected from one or more substituents) substituent Ariru group having a group, multi heterocyclic group (heterocyclic ring is as defined (7).), which may be identical or different, a halogen atom, Shiano group, a nitro group, (Ci ⁇ C 6) alkyl group, Nono b (Ci ⁇ C 6) alkyl group, (Ci ⁇ C 6) ⁇ Alkylcarbonyl group, (C Ce) alkoxy group or halo (a substituted heterocyclic group having one or more substituents selected from ( ⁇ -dialkoxy groups (heterocycles are the same as described above).) ,
- R 4 represents an amino group, a mono (Ci Cj alkylamino group or a monohalo (Ci Cj alkylamino group is excluded).
- R 4 excludes an alkyl group of (( ⁇ to j)).
- A is A 1 and Q 1 is a hydrogen atom, a halogen atom, a cyano group, a hydroxyl group, a carboxy group or one X 1 ! ⁇ 3 (wherein, X 1 is a single bond, -SOn- (wherein , n is an integer of 0 to 2), in -OS On- (wherein, n is as defined above), -CO-, one C0 2 -.., one OC0 2 - or one OC (O) - and R 3 is the same as (7).)
- Q 2 may be the same or different, and is a substituted aryl group having at least one substituent selected from a fluorinated (Ci Cj alkyl group, a fluorinated (Ci-Ce) alkoxy group or a fluorinated (di-to-alkylthio group)
- Q 1 is a (C ⁇ CJ alkyl group (X 1 is a single bond and R 3 is (C i C j alkyl group))
- Q 2 is substituted by at least one fluorine-containing alkyl group. Excluding substituted aryloxy groups.
- A is A 1
- Q 1 is a hydrogen atom, a halogen atom, a cyano group, a hydroxyl group, a carboxy group, a (Ci C ⁇ ) alkyl group, a halo (Ci-C 6 ) alkyl group, a (Ci-C 6) ⁇ alkoxy (Ji-Ji alkyl group, halo (Ji ⁇ Ji ⁇ alkoxy (Ji-Ji ⁇ Al kill group, (Ci ⁇ C 10) alkoxy group, halo (Ci ⁇ C 6) alkoxy, cyclo (C 3 -C 6) alkoxy group, Haroshikuro (C 3 -C 6) alkoxy groups, (Ci ⁇ C 6) an alkoxy (C ⁇ ) alkoxy groups, halo ( ⁇ Ji alkoxy ( ⁇ ) an alkoxy group, (Ci Ca) alkoxycarbonyl (C ⁇ CJ alkoxy group, (Amino) hydrate proxy
- alkylthio ( ⁇ ) an alkoxy group (Ci ⁇ C 6) alkyl sulphates enyl ( (Ci-C 6 ) alkoxy group, (Ci-C 6 ) alkylsulfonyl (Ci C alkoxy group, same or different Obviously better di (Ci ⁇ C 3) be Arukiruamino (Ci ⁇ C 3) alkoxy groups, (C 2 ⁇ C 6) alkenyl group, halo (C 2 ⁇ C 6) alkenyl group, human Dorokishiha port (C 2 -C 6 ) alkenyl group, (C 2 -C 6 ) alkoxy group, halo (C 2 -C 6 ) alkenyloxy group, (C 2 -C 6 ) alkynyloxy group, amino group, mono (di- Dialkylamino group, which may be the same or different di (CiCj alkylamino group, one or more halo which may be
- alkylsulfonyl group which may be the same or different, halogen atom, cyano group, (Ci-C 3 ) alkyl group, halo (Ci Cj alkyl group, ((:-Alkoxy group, halo (C CJ alkoxy group or halo (C-substituted phenyl group having one or more substituents selected from alkylthio groups, which may be the same or different, A substituted pyrazolyl group having at least one substituent selected from a halogen atom, a (Ci Ca) alkyl group or a halo (Ci Cj alkyl group), a furyl group, and one or more (di-to-alkyl groups) which may be the same or different; A substituted phenyl group, which may be the same or different, a substituted pyridyl group, which may be substituted with one or more halogen atoms, or a same or different,
- A is A2
- Q 1 is -OR 3 (where R 3 is the same as in (7))
- Q 2 is a hydrogen atom, a halogen atom, a hydroxyl group or _X 2 R 4 (wherein X 2 Is a single bond, —O—, —SOn— (where n is an integer of 0 to 2), —OSOn— (where n is the same as above), one C 0 2 _, one OC0 2 _ or one OC (O) represents one, and R 4 represents a (.
- alkyl group a halo (d ⁇ Co) alkyl group, a cyclo (C 3 -C 6 ) alkyl group, or a (Ci Cj alkoxy) (To) alkyl group, haloalkoxy (C ⁇ CJ alkynole group, (.-dialkylcyclo (C 3 -C 6 ) alkyl group, cyclo (C 3 -C 6 ) alkyl (C ⁇ CJ alkyl group, ( C ⁇ CJ alkoxycarbonyl ( ⁇ ) alkyl group, (C CJ alkylthio (C CJ alkyl group, (C Cj alkynolenorrebinol (Ci-C 4 ) alkyl group, ( ⁇ ) alkylsulfol (Ci-C 4) alkyl group, (c 2 to c 6) alkenyl, halo (c 2 to c 6) Aruke - group, human de proxy
- alkynyl group amino group, mono (Ci Ce) alkylamino group, mono (CiC alkylamino group, di- or di-halo which may be the same or different) (CiC alkylamino group, phenylamino group, which may be the same or different, halogen atom, cyano group, nitro group, hydroxyl group, amino group, SH group, alkyl group, halo ( ⁇ Cj alkyl group, cyclo ( C 3 -C 6) alkyl group, Haroshikuro (C 3 ⁇ C 6) alkyl groups, (C 2 ⁇ C 6) alkenyl group, Nono b (C 2 ⁇ C 6) an alkenyl group, (C 2 ⁇ C 6) Alkynyl group, halo (C 2 -C 6 ) alkyl group, (Ci-C 6 ) alkoxy group, halo (Ci Cj alkoxy group, (C ⁇ C ⁇ C ⁇
- alkylamino Bruno A substituted phenylamino group, an aryl group having one or more substituents selected from the group on the ring, or the same or different; a halogen atom, a cyano group, a nitro group, a hydroxyl group, an amino group, SH group, (Ci Ce) alkyl group, Nono port (( ⁇ -.
- ⁇ Alkynylamino) or di (dCe) alkylamino which may be the same or different
- R 4 represents an amino group, a mono (Ci Cj alkylamino group, a monohalo (dC alkylamino group, Or a di (C Ce) alkylamino group, which may be the same or different, a dihalo (Ci-C 6 ) alkylamino group, a phenylamino group, which may be the same or different, a halogen atom, a cyano group, a nitro group , Hydroxyl Group, amino group, SH group, (Ci-C 6 ) alkyl group, halo (di-di ⁇ alkyl group, (C 2 -C 6 ) alkenyl group, mouth (C 2 -C 6 ) alkenyl group, (C 2 to C
- A is A 2
- Q 1 is a halogen atom, a cyano group, a carboxy group or —X 1 R 3 (wherein X 1 is a single bond, —SOn_ (where n is an integer of 0 to 2) . which are shown), in one OSO n-(wherein the same as n in the) one CO-, one C0 2 -. one OC0 2 _ or show an OC (O) one, R 3 is (7) The same as above.)
- Q 2 may be the same or different, and a substituted aryl group having at least one substituent selected from a fluorinated (Ci to C 6 ) alkyl group, a fluorinated (Ci Cj alkoxy group or a fluorinated 6 ) alkylthio group, Fluorine-containing (d Cj alkyl group, fluorine-containing (Ci Cj alkoxy group or fluorine-containing (( ⁇ ⁇ .
- A is A2 and Q 1 is a halogen atom, a cyano group, a carboxy group, a (Ci-C 10 ) alkyl group, a halo (Ci Ce) alkyl group, a (C CJ alkoxy (Ci-C 6 ) Alkyl group, halo (C CJ alkoxy (d Cs) alkyl group, (C ⁇ Cio) anorecoxy group, halo (Ci Cj alkoxy group, cyclo (C 3 -C 6 ) anorecoxy group, halocyclo (C 3 -C 6 ) Alkoxy group, (.-dialkoxy (.-.
- alkylamino group the same or different and may be 1 or more halo (Ci C Al killed substituted substitution phenyl group with a group, pyrrolyl group, imidazolyl group, the same or may one or more even different dates (-.
- Q2 is a halogen atom, a hydroxyl group, (Ci Cj alkyl group, halo (Ji ⁇ . Alkyl group, a cycloalkyl (c 3 to c 6) alkyl group, Haroshikuro (c 3 to c 6) alkyl group, (( ⁇ -. ⁇ Alkoxy Group, haloalkoxy group, (( ⁇ ⁇ alkylthio group,
- alkylsulfide el group (Ji-Ji ⁇ alkylsulfonyl group, the same or different connexion is good, a halogen atom, Shiano group, (Ci ⁇ C 3) Arukinore groups, halo (Ci ⁇ C 3) alkyl group, (Ci C alkoxy group, halo (C 1 -C 3) alkoxy or halo (C A substituted or unsubstituted group having at least one substituent selected from an alkylthio group: a halogen atom, a cyano group, a (C i C alkyl group, a halo (d C alkyl group)
- the substituted chenobilimidine derivative according to (7) which is a substituted phenoxy group having one or more substituents selected from:
- R 1 represents a hydrogen atom, (( ⁇ to (alkyl group or halo 6 ) alkyl group
- R 2 represents a hydrogen atom, a halogen atom, (Ci Cj alkyl group or halo (Ci C alkyl group. )
- a 2
- Y represents a halogen atom
- Q 2a may be the same or different and is at least one substituent selected from a fluorine-containing (Ci-Cj alkyl group, a fluorine-containing (Ci-C 6 ) alkoxy group and a fluorine-containing (Ci-C 6 ) alkylthio group Having one or more substituents selected from the group consisting of a fluorine-containing (di- to ⁇ alkyl group, a fluorine-containing (CiCe) alkoxy group and a fluorine-containing (CiCalkylthio group) which may be the same or different.
- R 3 represents a (Ci Cio) alkyl group, a halo (C ⁇ Co) alkyl group, or a cyclo (c 3 -c 6 ) alkyl groups, halo (c 3 to c 6) a cycloalkyl group, (C CJ alkoxy (Ci Cj alkyl group, halo 6) alkoxy (C ⁇ CJ-alkyl group, ( ⁇ ) Arukirushiku port (C 3 -C 6) Al kill Group, cyclo (C 3 -C 6 ) alkyl (C CJ alkyl group, (-( 3 ) alkoxycarbonyl (Ci-Ca) alkyl group, (di) alkylthio-) alkyl group, (-!) Alkylsulfinyl ⁇ ) Alkyl group, (Ci-C 4 ) alkylsulfon
- alkenyl group human Dorokishi (c 2 ⁇ c 6) alkenyl group, human Dorokishiha port (c 2 ⁇ c 6) alkenyl, phenyl (c 2 ⁇ c 6) alkenyl group, (c 2 ⁇ c 6) alkynyl group, halo (C 2 -C 6) alkynyl group, an amino group, a mono (Ci Ce) Al Kiruami amino group, monohalo (( ⁇ -. ⁇ alkylamino amino group, the same or different dates be good di (Ci Cj alkyl Amino group, dihalo which may be the same or different
- Alkyl Snorefiel group cyclo (C 3 -C 6 ) alkyl Snorefinyl group, halocyclo (C 3 -C 6 ) alkylsulfinyl group, (j-j ⁇ alkylsulfonyl group, halo (.
- R 1 represents a hydrogen atom, (C CJ alkyl group or halo (CiC alkyl group, R 2 represents a hydrogen atom, halogen atom, (Ci Cj alkyl group or halo ((-. Alkyl group. Y may be the same or different, and 2, 4 one Jiharogenochieno [2, 3-d] pyrimidine derivative represented by a halogen atom.), the formula (IV)
- Q 2a may be the same or different, and is a fluorinated (Ci Ce) alkyl group, a fluorinated (one or more selected from a ( ⁇ to ( 6 ) alkoxy group or a fluorinated (Ci Ce) alkylthio group)
- L represents _B (OH) 2.
- the compound represented by the formula (1-3) is subjected to a coupling reaction.
- R 1 represents a hydrogen atom, a (C Ce) alkyl group or a halo (Ci C alkyl group)
- R 5 represents a hydrogen atom, a halogen atom, (Ci Cj alkyl group or halo (d Cj alkyl group
- R 6 represents a fluorine-containing (Ci Cj alkyl group, a fluorine-containing (Ci Cj alkoxy group or a fluorine-containing (d Ce ) Represents an alkylthio group.
- 2-amino-3- (substituted benzoyl) thiophene derivative represented by the formula:
- R 1 represents a hydrogen atom, (Ci Cj alkyl group or halo (Ci Cj alkyl group
- R 2 represents a hydrogen atom, halogen atom, (C CJ alkyl group or halo (Ci Cj alkyl group. or different same or or or Ariru group, a halogen atom, Shiano group, a nitro group, (C CJ alkyl, halo 6) alkyl group, (C x
- R 5 represents a hydrogen atom, a halogen atom, (Ci Cj alkyl group or halo (Ci Cj alkyl group
- R 6 represents a fluorine-containing (Ci Cj alkyl group, a fluorine-containing (d Ce) alkoxy group or a fluorine-containing
- the substituted chenobilimidine derivative useful as a herbicide in the present invention is represented by the general formula (I), and has found use as a novel herbicide.
- R 1 in the general formula (I) is a hydrogen atom or an optionally substituted alkyl group.
- the substituent of the alkyl group is not particularly limited as long as the compound exhibits the herbicidal activity, and examples thereof include a halogen atom such as a fluorine atom, a chlorine atom, a bromine atom and an iodine atom.
- the alkyl group which may be substituted preferably has 1 to 6 carbon atoms, and more preferably has 1 to 4 carbon atoms.
- alkyl group which may be substituted include a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, an isoptyl group and the like.
- R 2 is a hydrogen atom; a halogen atom such as a fluorine atom, a chlorine atom, a bromine atom and an iodine atom; or an alkyl group which may be substituted.
- a halogen atom such as a fluorine atom, a chlorine atom, a bromine atom and an iodine atom
- an alkyl group which may be substituted examples include the same groups as those for R 1 above.
- R 2 is preferably a hydrogen atom or a halogen atom.
- Q 1 represents a hydrogen atom; or a group represented by one chi 1 ⁇ 3; Shiano group; a hydroxyl group; a carboxyl group! Fluorine atom, a chlorine atom, a bromine atom, a halogen atom such as iodine atom.
- X 1 is a single bond, one O—, —SOn— (where n represents an integer of 0 to 2), and one OSOn— (Wherein n is as defined above), one CO—, one co 2 —, one oco 2 — or one OC (O) one, preferably a single bond, _o_, one S— or one so 2 — And particularly preferably 1 O—.
- R 3 is an optionally substituted alkyl group, an optionally substituted alkenyl group, an optionally substituted alkynyl group, or an optionally substituted Good amino group, optionally substituted aryl group or substituted It is a good heterocyclic group.
- the heterocyclic ring of the heterocyclic group include a 5- or 6-membered heterocyclic ring having one or more heteroatoms selected from an oxygen atom, a sulfur atom, and a nitrogen atom. Examples thereof include oxysilane, oxetane, tetrahydrofuran, and furan.
- the substituent of the above-mentioned alkyl group, alkenyl group, alkynyl group, amino group, aryl group and heterocyclic group is not particularly limited as long as the compound exhibits herbicidal activity.
- the alkyl group, alkenyl group and alkynyl group preferably have 1 to 10 carbon atoms, more preferably have 1 to 6 carbon atoms, and have the amino group, aryl group and heterocyclic group.
- the ring group preferably has 15 or less carbon atoms, more preferably 12 or less carbon atoms, and particularly preferably 10 or less carbon atoms.
- R 3 is preferably a halogen atom, an alkyl group which may be substituted, an alkenyl group which may be substituted, an alkyl group which may be substituted, an aryl group which may be substituted. Or a substituted or hetero-substituted group.
- R 3 examples include a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, an isobutyl group, a sec-butyl group, a tert-butyl group, a pentyl group, a bispentyl group, a hexyl group, (C i C) alkyl groups such as isohexyl, heptyl, octyl, nonyl, and decyl;
- Cycle (C 3 -C 6 ) alkyl groups such as cyclopropyl, cyclobutyl, cyclopentyl, and cyclohexyl;
- (2,2,2-Trifluoroethoxy) methyl group 2- (2,2,2-Trifluoroenoethoxy) ethyl group, 3- (2,2,2-Trifluoroethoxy) propyl group, 4 — (2,2,2-Trifluoroethoxy) butyl group, 5- (2,2,2-Trifluoroethoxy) pentinole group, 6- (2,2,2-Triethoxynorethoxy) hexyl group, 1-methyl-2- (2,2,2-trifluoroethoxy) ethyl group, (trifluoromethyl) ethyl group,
- Cyclo (C 3) such as cyclopropylmethyl, 2_ (cyclopropyl) ethyl, 3- (cyclopropyl) propyl, 4- (cyclopropyl) butyl, cyclobutylmethyl, cyclopentylmethyl, cyclohexylmethyl, etc. ⁇ C 6 ) alkyl
- Methylthiomethyl group ethylthiomethyl group, propylthiomethyl group, butylthiomethyl group, 1- (methylthio) ethyl group, 2- (methylthio) ethyl group, 3- (methinorethio) propyl group, 4- (methylthio) butyl group, etc. (Ci Cj alkylthio (Ci-C 4 ) alkyl group;
- Methylsulfinylmethyl group ethinolesulfinylmethyl group, propylsulfinylmethyl group, butylsulfinylmethynole group, 1- (methylsulfenyl) ethyl group, 2- (methylsulfinyl) ethyl group, 31- (methylsulfinyl) propyl group, Four- (C ⁇ cj alkylsulfoninole (-) alkyl group such as (methylsulfinyl) butyl group;
- C 2- (: 6 ) alkenyl groups such as 2-methyl_2-butenyl group, 3-methyl_2-butenyl group, 4-pentenyl group, and 5-hexeninole group;
- C- (C 2 -C 6 ) alkenyl groups such as 2-chloroaryl group, 3_chloroaryl group, 4-chloro-2-1-2puturyl group;
- (C 2 -C e ) alkynyl groups such as ethynyl group, propargyl group, monomethylpropargyl group, 2-pentynyl group, 3-pentyl group, 4-pentyl group and 5-hexyl group;
- Halo (C 2 -C 6 ) alkynyl groups such as 3-chloroprononoregyl group, 4 mono-l-butininole group, 5_chloro-3_pentynyl group;
- Phenyl group 2-methylphenyl group, 3-methylphenyl group, 4-methylphenyl group,
- Amino group methylamino group, dimethylamino group, ethylamino group, getylamino group, methylethylamino group, propylamino group, isopropylamino group, butylamino group, phenylamino group, 2-methylphenylamino group, 3-methylphenyl Amino, 4-methylphenylamino, 2-fluorophenylamino, 3-fluorophenylamino, 4-fluorophenylamino, 2- (trifluoromethyl) phenylamino, 3- ( Trifluoroamino) phenylamino, 4- (trifluoromethyl) phenylamino, 2 _ (trifluoromethoxy) phenylamino, 3- (Fluorometoxy) phenylinamino, 4- (trifluoromethyl) phenylamino, 2-chlorophenylamino, 3-chlorophenylamino, 4-chloropheny
- Q 1 is preferably a case where Q 1 is a group represented by OR 3 , and preferred specific examples include a methoxy group, an ethoxy group, a propoxy group, an isopropoxy group, a butoxy group, a tert-butoxy group, (C Ce) alkoxy groups such as pentyloxy and hexyloxy groups;
- Cyclo (C 3 -C 6 ) alkoxy groups such as cyclopropoxy, cycloptoxy, cyclopentynoleoxy, cyclohexyloxy;
- Halo (C 2 -C 4 ) alkenyloxy groups such as 2-chloroallyloxy group, 3_chloroallyloxy group, and 4-chloro-2-hydroxyl group;
- (C 2 -C 4 ) alkynyloxy groups such as ethynyloxy group, propargyloxy group, ⁇ -methylpropargyloxy group, 2-butynyloxy group and 3-butyl-loxy group;
- Halo such as 3-cyclopropargyloxy group and 4-chloro-2-pentynyloxy group
- a heterocyclic oxy group such as an oxy group, an 11-imidazolyloxy group, and a phenoxy group or a benzyloxy group (the heterocyclic oxy group, the phenoxy group, and the benzyloxy group are a halogen atom, a Ci to C 3 alkyl group, a C 3 to C 6 cycloalkyl group, C ⁇ C 2 haloalkyl groups and C ⁇ C 3 alkoxy substituents selected from the group consisting of groups may be substituted.), and the like, more preferably (C Cs) alkoxy Or a haloalkoxy group.
- Q 2 is a hydrogen atom; a halogen atom such as a fluorine atom, a chlorine atom, a bromine atom and an iodine atom; a hydroxyl group; or a group represented by X 2 R 4 .
- X 2 includes the same group as X 1 described above, and R 4 includes the same group as R 3 described above.
- Q 2 is preferably
- Alkylthio groups such as methylthio, ethylthio, propylthio, isopropylthio, butylthio, isoptylthio, sec-butylthio, tert-butylthio, pentylthio, isopentylthio, hexylthio, etc., and methylsulfinyl Group, ethylsulfinyl group, propylsulfinyl group, isopropylsulfinyl group, butylsulfinyl group, isobutylsulfinyl group, sec-butylsulfinyl group, tert -Alkylsulfinyl group such as butylsulfonyl group, pentylsulfininole group, isopentylsulfininole group, hexylsulfinyl group or methylsulfonyl group,
- 1,2-methyl-1,2,2,2-trifluoroethyl, 2,2,2-trifluoro-1- (trifluoromethyl) ethyl, 1,1-methyl-1,2,3 Fluorine-containing alkyl groups such as, 3,3-pentafluoropropyl group, fluoromethoxy group, difluoromethoxy group, trifluoromethoxy group, 2-fluoroethoxy group, 2,2-difluoroethoxy group, 2,2 2_Trifluoroethoxy, 3-fluoropropoxy, 3,3,3-Trifluoropropoxy, 2,2,3,3-Tetrafluoropropoxy, 2,2,3 1,3,3-pentafluoropropoxy group, 1-methyl-1,2,2,2-trifluoroethoxy group, 2,2,2-trifluoro-11- (trifluoromethyl) ethoxy group, 1-methyl-2 Fluorine-containing alkoxy groups such as 2,2,3,3,3-pentafluoropropoxy group Difluoromethylthio, tri
- a heterocyclic group or a heterocyclic oxy group which may be substituted with a substituent selected from the group consisting of a fluorinated alkyl group, a fluorinated alkoxy group and a fluorinated alkylthio group as described above.
- Heterocycle, an oxygen atom exemplified above Q 1 is a 5 or 6-membered heterocyclic ring having 1 or more heteroatoms selected from oxygen, sulfur or nitrogen atoms.
- the fluorine alkylthio group is preferably C Ce, and more preferably ⁇ C 4 .
- Preferred specific examples of arylsulfonyl groups include 2- (fluoromethyl) phenyl, 2- (fluoromethoxy) phenyl, 2- (fluoromethylthio) phenyl, and 3- (fluoromethyl) phenyl Group, 3- (fluoromethoxy) phenyl, 3- (fluoromethylthio) phenyl, 4- (fluoromethyl) phenyl, 4- (fluoromethoxy) phenyl, 4- (fluoromethylthio) phenyl Group, 2- (difluoromethyl) phenyl group,
- a 3- (fluoromethyl) phenyl group a 3- (fluoromethoxy) phenyl group, a 3- (phenylolemethinoretio) phenyl group, a 3- (difluoromethinole) phenyl group, and a 3- (difluoromethyl) phenyl group are preferred.
- Toxi phenyl group, 3- (difluoromethylthio) phenyl group, 3- (trinorolemethinole) phenyl group, 3- (trifluoronoreomethoxy) phenyl group, 3- (trifluoromethylthio) ) Phenyl, 3- (2-fluoroethyl) phenyl, 3- (2-fluoroethoxy) phenyl, 3- (2-fluoroethylthio) phenyl, 3- (2,2-difluoroethyl) phenyl, 3- (2,
- heterocyclic group or heterocyclic oxy group which may be substituted with a substituent selected from the group consisting of the above-mentioned fluorinated alkyl group, fluorinated alkoxy group and fluorinated alkylthio group is preferably substituted with these substituents. And a nitrogen-containing 5- or 6-membered ring.
- heterocyclic group or heterocyclic oxy group which may be substituted with a substituent selected from the group consisting of a fluorinated alkyl group, a fluorinated alkoxy group and a fluorinated alkylthio group include:
- the compounds represented by the general formula (I) used as the herbicide of the present invention are novel compounds, and are more preferable as herbicides.
- the compounds described below are novel compounds, and are more preferable as herbicides.
- R 1 and R 2 are the same as above, and when Q 1 is one OR 3 (R 3 is the same as above), Q 2 is a hydrogen atom; a fluorine atom, a chlorine atom A halogen atom such as an atom or a bromine atom; a hydroxyl group or 1 X 2 R 4 (wherein X 2 and R 4 are the same as described above).
- R 4 represents an amino group, mono (Ci Cj alkylamino group and monohalo (excluding Ci Cj alkylamino group, and when X 2 is 10—, R 4 represents (C alkyl Excluding group.
- A is A 1, R 1 and R 2 are the same as above, and Q 1 is a hydrogen atom; a fluorine atom, A halogen atom such as a chlorine atom or a bromine atom; a hydroxyl group or — ⁇ 1 ! ⁇ 3 , X 1 is a single bond, -SOn- (where n is the same as above), -OSOn- (where n wherein the same), one CO-, _co 2 _, one OC0 2 -. or _OC (O) -.
- Q 2 is a fluorine-containing alkyl group, fluorine-containing alkoxy group and containing An aryl group, an aryloxy group, an arylthio group, an arylsulfinyl group or an arylsulfonyl group, which is at least one substituted with a substituent selected from the group consisting of a fluorine alkylthio group.
- Q 1 represents a (C i C j alkyl group (wherein is a single bond and represents a C i C j alkyl group)
- Q 2 is at least one-substituted by a fluorine-containing alkyl group. Excluding substituted aryloxy groups.
- A is A2
- R 1 and R 2 are the same as above, and when Q 1 is -OR 3 , Q 2 is a hydrogen atom; a halogen atom such as a fluorine atom, a chlorine atom, and a bromine atom
- Q 2 is a hydrogen atom; a halogen atom such as a fluorine atom, a chlorine atom, and a bromine atom
- X 2 is a single bond, —SOn— (where n is the same as above), —OSOn— (where n is the same as above), one CO_, _C0 2 -, - OC0 2 - or _OC (O) Ri Ah
- R 4 is an optionally substituted alkyl group, an optionally substituted alkenyl group, it may also be substituted, an alkynyl group, which may be substituted A good amino group or an aryl group which may be substituted.
- R 4 excludes an optionally substituted amino group and an optionally substituted alkyl group.
- A is A 2
- R 1 and R 2 are the same as above, and Q 1 is a halogen atom such as a fluorine atom, a chlorine atom, and a bromine atom; a hydroxyl group or —X 1 ! ⁇ 3 ; 1 is a single bond, 1 SOn—
- Q 2 is at least one substituted with a substituent selected from the group consisting of a fluorine-containing alkyl group, a fluorine-containing alkoxy group, and a fluorine-containing alkylthio group, and is preferably an aryl group, an aryloxy group, A thiol group, a phenylsulfenyl group or an arylsulfonyl group.
- Q 2 represents an aryl group, an aryloxy group, an arylthio group, an arylsulfinyl group, which is at least one substituted with a substituent selected from the group consisting of a fluorine-containing alkyl group, a fluorine-containing alkoxy group and a fluorine-containing alkylthio group.
- a substituent selected from the group consisting of a fluorine-containing alkyl group, a fluorine-containing alkoxy group and a fluorine-containing alkylthio group.
- an arylsulfonyl group is preferred.
- a compound in which A is A 1 and Q 1 is a halogen atom or a hydroxyl group itself has herbicidal activity, but is an intermediate in synthesizing another compound used as a herbicide of the present invention. Is also useful.
- the compound represented by the general formula (I) may be a known method, a method based thereon, or The compound can be arbitrarily prepared by combining these methods, and particularly, the novel compound is preferably prepared by the following methods 1 to 8. Manufacturing method 1
- R 7 represents a methyl group, an ethyl group or a propyl group
- R 8 represents an alkylsulfonyl group, an arylsulfonyl group. Represents a group, an acyl group, or an optionally substituted canolebamoyl group
- ha 1 represents a halogen atom.
- Step 11 is a step of reacting an ester derivative represented by the general formula (VIII) with acetonitrile to produce an acylacytonitrile derivative represented by the general formula (IX).
- 3-((trifluoromethoxy) ethyl benzoate is a novel compound, and among the acylacetonitrile derivatives represented by the general formula (IX), the following general formula (VII)
- R 5 represents a hydrogen atom, a halogen atom or an optionally substituted alkyl group
- R 6 represents a fluorinated alkyl group, a fluorinated alkoxy group or a fluorinated alkylthio group, provided that R 6 is In the case of a fluorine-containing alkyl group, R 5 is not a hydrogen atom.
- the substituted benzoylacetonitrile derivative represented by the formula is a novel compound.
- the reaction in this step is preferably performed in the presence of a base from the viewpoint of yield.
- a base examples include sodium hydride, potassium hydrogen hydride, lithium amide, sodium amide, and lithium diamide.
- Alkali metal bases such as isopropylamide (LDA), n-butyllithium, sec-butyllithium, butyllithium, lithiumhexamethyldisilazide, and potassium-t-butoxide can be used.
- LDA isopropylamide
- n-butyllithium, sec-butyllithium, butyllithium, lithiumhexamethyldisilazide, and potassium-t-butoxide can be used.
- the target product can be obtained in good yield by using 0.1 to 2.0 equivalents of the base relative to the substrate.
- This reaction can be carried out in a solvent, and any solvent that does not harm the reaction can be used.
- the solvent include nitrile solvents such as acetonitrile; aromatic hydrocarbon solvents such as benzene, toluene, and xylene; aliphatic hydrocarbon solvents such as pentane, hexane, and octane; getyl ether, disopropyl, and the like.
- Ether-based solvents such as ether, tetrahydrofuran (THF), dimethoxyethane (DME), and 1,4-dioxane; liquid ammonia; or solvents that do not harm the reaction, such as mixed solvents, must be used.
- THF tetrahydrofuran
- DME dimethoxyethane
- 1,4-dioxane liquid ammonia
- solvents that do not harm the reaction such as mixed solvents, must be used.
- the reaction can be carried out at a temperature appropriately selected from the range of -78 to the solvent reflux temperature to obtain the desired product in good yield.
- each reactant may be used in an equimolar amount, but any of them may be used in excess.
- reaction product can be isolated by a conventional method and, if necessary, purified by recrystallization, silica gel column chromatography, or another operation. It can also be used for the next reaction without isolation.
- Step_2 is a reaction of an acylacetonitrinole derivative represented by the general formula (IX), a compound represented by the general formula (X) and sulfur, and a 2-aminothiophene represented by the general formula (XI) This is a step of producing a derivative.
- the 2-aminothiophene derivatives represented by the general formula (IX) the following general formula (V)
- the 2-amino-3- (substituted benzoyl) thiophene derivative represented by is a novel compound.
- This step can be performed according to the method described in J. Med. Chera. 1973, Vol. 16, page 214, and is preferably performed in the presence of a base from the viewpoint of yield.
- bases include triethylamine, diisopropylethylamine, triptylamine, N-methylmorpholine, N, N-dimethinoreadiline (DMA), N, N-getylalanine, 4-t-butylethyl N, N— Dimethylylaniline, pyridine, 4- (dimethylamino) pyridine (DMAP), picoline, norethidine, 1,5-diazabicyclo [5.4.0] indene 5-Dene (DBU), 1,4- Organic bases such as diazabicyclo [2.2.2] octane (DAB CO) and imidazole, sodium hydride, potassium hydride, lithium amide, sodium amide, lithium isopropyl amide (LDA), butyllithium, t-butyllith
- This reaction can be carried out in a solvent, and any solvent that does not harm the reaction can be used.
- the solvent include amide solvents such as N, N-dimethinoleformamide (DMF), N, N-dimethylacetoamide (DMAC), and N-methinolepyrrolidone (NMP): benzene, toluene, xylene, and benzene Aromatic hydrocarbon solvents such as pentane, hexane, octane, etc .; Getyl ether, diisopropyl ether, tetrahydrofuran (THF), dimethoxetane (DME), 1,4-dioxane, etc.
- Ether solvents such as dimethylsulfoxide (DMSO), methanol, ethanol, isopropanol (IPA) and the like; or solvents that do not harm the reaction such as a mixed solvent thereof can be used. .
- the reaction can be carried out at a temperature appropriately selected from the range of from 0 to the solvent reflux temperature to obtain the desired product with good yield.
- each reactant may be used in an equimolar amount, but any of them may be used in excess.
- reaction product can be isolated by a conventional method and, if necessary, purified by recrystallization, silica gel column chromatography, or another operation. It can also be used for the next reaction without isolation.
- step 3 the 2-aminothiophene derivative represented by the general formula (XI) is reacted with a urea to form a 2-hydroxythieno [2,3_d] pyrimidine derivative represented by the general formula (XII). This is the manufacturing process.
- This step can be performed according to the method described in Chem. Pharm. Bull., 1980, Vol. 28, page 3172.
- Solvents include amide solvents such as ⁇ , ⁇ -dimethylformamide (DMF), N, N-dimethylacetamide (DMAC), N-methylpyrrolidone (NMP); acetonitrile, propionitrile Acetonitrile solvents such as benzene, toluene, xylene, and benzene; aliphatic hydrocarbon solvents such as pentane, hexane, and octane; getyl ether, diisopropyl ether, and the like.
- amide solvents such as ⁇ , ⁇ -dimethylformamide (DMF), N, N-dimethylacetamide (DMAC), N-methylpyrrolidone (NMP); acetonitrile, propionitrile Acetonitrile solvents such as benzene, toluene, xylene, and benzene
- aliphatic hydrocarbon solvents such as pentane, hexane,
- Ether solvents such as tetrahydrofuran (THF), dimethoxetane (DME) and 1,4-dioxane; dimethyl sulfoxide (DMSO), methanol, ethanol Any solvent that does not harm the reaction can be used, such as alcoholic solvents such as toluene and isopropanol (IPA); or mixed solvents thereof.
- the target product can be obtained with good yield by performing the reaction at a temperature appropriately selected from the range of room temperature to the solvent reflux temperature.
- each reactant may be used in an equimolar amount, but any of them may be used in excess.
- reaction product can be isolated by a conventional method and, if necessary, purified by recrystallization, silica gel column chromatography, or another operation. It can also be used for the next reaction without isolation.
- Step_4 comprises halogenating the hydroxy group of the 2-hydroxythieno [2,3-d] pyrimidine derivative represented by the general formula (XII) using a halogenating agent, and formulating the compound represented by the general formula (1-4). This is a step of producing a thieno [2,3_d] pyrimidine derivative to be used.
- This step can also be performed according to the method described in Chem. Pharm. Bull., 1980, Vol. 28, p. That is, as the halogenating agent used in this step, it is possible to use a halogenating agent such as sulfuryl chloride, thioyrc chloride, oxychloride phosphorus, phosgene, phosphorus trichloride, phosphorus pentachloride, phosphorus tribromide and the like. it can.
- a halogenating agent such as sulfuryl chloride, thioyrc chloride, oxychloride phosphorus, phosgene, phosphorus trichloride, phosphorus pentachloride, phosphorus tribromide and the like. it can.
- alkylamines such as triethylamine, disopropylethylamine, and triptylamine, ⁇ , ⁇ -dimethylformamide (DMF), N, N-dimethylacetamide, N, N-dimethylaniline, N, N—
- DMF ⁇ , ⁇ -dimethylformamide
- the amount used is about 0.1 to 2 equivalents to the substrate.
- This reaction can be carried out in a solvent, and any solvent that does not harm the reaction can be used.
- a solvent water; aromatic hydrocarbon solvents such as chlorobenzene, dichlorobenzene and the like; halogenated hydrocarbon solvents such as chloroform, dichloromethane, tetrachlorocarbon and the like; or mixed solvents thereof can be used. .
- the target product can be obtained in good yield by performing the reaction at a temperature appropriately selected from the range of 120 ° C. to the solvent reflux temperature.
- each reactant may be used in an equimolar amount, but any of them may be used in excess.
- reaction product can be isolated by a conventional method and, if necessary, purified by recrystallization, silica gel column chromatography, or another operation. It can also be used for the next reaction without isolation.
- Step-1 is represented by a thieno [2,3-d] pyrimidine derivative represented by the general formula (1-4) and a general formula (II) (wherein, R 3 and X 1 are the same as described above).
- This is a step of producing a thieno [2,3-d] pyrimidine derivative represented by the general formula (I-15) by reacting with a compound represented by the general formula (I-15).
- the reaction in this step is preferably performed in the presence of a base from the viewpoint of yield.
- bases include sodium hydrogen sodium, potassium hydride, lithium amide, sodium amide, lithium diisopropylamide (LDA), n-butyl lithium, sec-butyl lithium, butyl lithium, and trimethinoresilinorelithium.
- Lithium hexamethyldisilazide sodium carbonate, potassium carbonate, sodium hydroxide, potassium hydroxide, sodium methoxide, sodium ethoxide, alkali metal bases such as potassium t-butoxide, triethylamine, disopropyl Ethiluamine, triptyluamine, N-methylmorpholine, N, N-dimethinorea diline (DMA), N, N_ dimethylylurine, 4-t-butyl-N, N-dimethylaniline, pyridine, 4- (dimethylamino ) Pyridine (DMAP), picoline, lutidine, 1, 5 Jiazabishikuro [5.4.0] Undeku 5- E emissions (DBU) ⁇ 1, 4- Jiazabishikuro [2.2.2] octane (DABCO), it can be used organic bases such as imidazole.
- the target compound can be obtained in good yield by using 0.1 to 2.0 equivalents of the base relative to the substrate.
- This reaction can be carried out in a solvent, and any solvent that does not harm the reaction can be used.
- the solvent include water; amide solvents such as N, N-dimethylformamide (DMF), N, N-dimethylacetamide (DMAC), and N_methylpyrrolidone (NMP); acetonitrile, propionitrile Solvents such as benzene, toluene, xylene, and benzene; aliphatic hydrocarbon solvents such as pentane, hexane, and octane; getyl ether, diisopropyl ether, and tert.
- amide solvents such as N, N-dimethylformamide (DMF), N, N-dimethylacetamide (DMAC), and N_methylpyrrolidone (NMP)
- acetonitrile, propionitrile Solvents such as benzene, toluene, xylene, and benzene
- Ether solvents such as trahydrofuran (THF), dimethoxetane (DME) and 1,4-dioxane; alcohol solvents such as dimethyl sulfoxide (DMSO), methanol, ethanol and isopropanol (IPA); or these Any solvent which does not harm the reaction, such as a mixed solvent of the above, can be used.
- THF trahydrofuran
- DME dimethoxetane
- IPA isopropanol
- the reaction can be carried out at a temperature appropriately selected from the range of -78 ° C to the reflux temperature of the solvent to obtain the desired product in good yield.
- reaction product can be isolated by a conventional method and, if necessary, purified by recrystallization, silica gel column chromatography, or another operation. It can also be used for the next reaction without isolation.
- Step _6 comprises thieno [2,3-d] pyrimidine derivatives represented by the general formula (1-5), wherein X 1 is a compound represented by -S-, and the compound represented by the general formula (1-5) This is a process for producing a thieno [2,3-d] pyrimidine derivative represented by 6).
- This step can be carried out by using an oxidizing agent.
- the oxidizing agent to be used include oxidizing agents such as m-mouth perbenzoic acid, aqueous hydrogen peroxide and peracetic acid.
- This reaction can be carried out in a solvent, and any solvent that does not harm the reaction can be used.
- the solvent include water; aromatic hydrocarbon solvents such as tonolen, benzene, and dichlorobenzene; halogenated hydrocarbon solvents such as chlorophonolem, dichloromethane, and carbon tetrachloride; acetic acid; and a mixed solvent thereof.
- the reaction can be carried out at a temperature appropriately selected from the range of ⁇ 20 ° C. to the solvent reflux temperature to obtain the desired product in good yield.
- each reactant may be used in an equimolar amount, but any of them may be used in excess.
- reaction product can be isolated by a conventional method and, if necessary, purified by recrystallization, silica gel column chromatography, or another operation.
- step 17 the 2-hydroxythieno [2,3-d] pyrimidine derivative represented by the general formula ( ⁇ ) is reacted with the compound represented by the general formula (XIII), and the compound represented by the general formula (1—
- the reaction in this step is preferably performed in the presence of a base or a trialkylammonium chloride such as trimethylamine hydrochloride.
- Bases include triethylamine, diisopropylethylamine, triptylamine, N-methylmorpholine, N, N-dimethylylaniline (DMA), N, N_Jetylaniline, 4-t-butylethyl N, N-dimethyoleaniline, pyridine , 4- (dimethylamino) pyridine (DMAP), picoline, lutidine, 1,5-diazabicyclo [5.4.0] indene 5-ene (DBU), 1,4 diazabicyclo [2.2.2] octane (DABCO), An organic base such as imidazole can be used.
- the base or trialkylammonium chloride is used in an amount of 0.1 to 2.0 equivalents to the substrate, so that the desired product can be obtained in good yield.
- This reaction can be carried out in a solvent, and any solvent that does not harm the reaction can be used.
- the solvent include water; amide solvents such as N, N-dimethylformamide (DMF), N, N-dimethylacetamide (DMAC), and N_methylpyrrolidone (NMP); and solvents such as acetonitrile and propionitrile.
- Nitrile solvents aromatic hydrocarbon solvents such as benzene, toluene, xylene, and benzene; aliphatic hydrocarbon solvents such as pentane, hexane, and octane; getyl ether, diisopropyl ether, tetrahydro
- solvents such as furan (THF), dimethoxetane (DME), ether solvents such as 1,4-dioxane; dimethylsulfoxide (DMSO); be able to.
- the target product can be obtained in good yield by performing the reaction at a temperature appropriately selected from the range of -78 ° C to the solvent reflux temperature.
- each reactant may be used in an equimolar amount, but any of them may be used in excess.
- After completion of the reaction it can be isolated by a conventional method, and if necessary, can be purified by recrystallization, silica gel column chromatography, or the like. Manufacturing method 1 2
- step 8 the acylacetonitrile derivative represented by the general formula (IX) is reacted with 2,5-dihydroxy-1,4-dithiane represented by the formula (XIV) to obtain a compound represented by the general formula (XV)
- step 8 This is a process for producing a 2-aminothiophene derivative represented by the following formula.
- Bases include: triethylamine, diisopropylethylamine, triptylamine, N-methylmorpholine, N, N-dimethylaniline (DMA), N, N_Jetylaniline, 4-t-butyl-N, N— Dimethylaniline, pyridine, 4- (dimethylamino) pyridine (DMAP), picoline, noretidine, 1,5-diazabicyclo [5.4.0] pentadec-5-ene (DBU), 1,4 diazabicyclo [2.
- octane DABCO
- organic bases such as imidazole, sodium hydride, potassium hydride, lithium amide, sodium muamide, lithium diisopropylamide (LDA), butyllithium, t-butyllithium, trimethylinoresili Norelithium, lithium hexamethyldisilazide, sodium methoxide, sodium ethoxide, potassium tert-oxide, etc.
- the alkali metal base or the like can and Mochiiruko.
- the target can be obtained in good yield by using 0.1 to 2.0 equivalents of the base relative to the substrate.
- This reaction can be carried out in a solvent, and any solvent that does not harm the reaction can be used.
- the solvent include water; amide solvents such as N, N-dimethylformamide (DMF), N, N-dimethylacetamide (DMAC), and N-methylpyrrolidone (NMP); acetonitrile, propio-tolyl Solvents such as benzene, toluene, xylene, and benzene; aliphatic hydrocarbon solvents such as pentane, hexane, and octane; getyl ether, diisopropyl ether, and Ether solvents such as trahydrofuran (THF), dimethoxetane (DME), and 1,4-dioxane: dimethyl sulfoxide (DMSO); methanol, ethanol, iso- An alcohol solvent such as propanol (IPA); or a solvent that does not harm the reaction such as a mixed solvent thereof can
- the reaction can be carried out at a temperature appropriately selected from the range of from 0 to the solvent reflux temperature to obtain the desired product with good yield.
- each reactant may be used in an equimolar amount, but any of them may be used in excess.
- reaction product can be isolated by a conventional method and, if necessary, purified by recrystallization, silica gel column chromatography, or another operation. It can also be used for the next reaction without isolation.
- X 3 represents a single bond, 10- or 1S—
- R 9 represents an optionally substituted amino group, Represents an optionally substituted alkyl group or an optionally substituted aryl group.
- step 9 the aminothiophene derivative represented by the general formula (XI) and the haloacetonitrile represented by the general formula (XVI) are reacted in the presence of a Lewis acid such as aluminum salt to form a compound represented by the general formula (1—
- a Lewis acid such as aluminum salt
- This step can be performed according to the method described in J. Med. Chem., 1996, Vol. 39, No. 16, page 5176.
- This reaction can be carried out in a solvent, and any solvent that does not harm the reaction can be used.
- a solvent water; an aromatic hydrocarbon solvent such as benzene and dichlorobenzene; a hydrogenated solvent such as chloroform, dichloromethane and carbon tetrachloride; and a mixed solvent thereof.
- an aromatic hydrocarbon solvent such as benzene and dichlorobenzene
- a hydrogenated solvent such as chloroform, dichloromethane and carbon tetrachloride
- a mixed solvent thereof can be.
- the reaction can be carried out at a temperature appropriately selected from the range of from 0 to the solvent reflux temperature to obtain the desired product with good yield.
- each reactant may be used in an equimolar amount. It can be used in excess.
- reaction product can be isolated by a conventional method and, if necessary, purified by recrystallization, silica gel column chromatography, or another operation. It can also be used for the next reaction without isolation.
- Step-10 is a reaction of the thieno [2,3-d] pyrimidine derivative represented by the general formula (1-8) with the compound represented by the general formula (XVII) in the same manner as in the step 15 described above.
- Step 1-11 comprises reacting an aminothiophene derivative represented by the general formula (XI) with glyoxylic acid and ammonium acetate to form a thieno [2] represented by the general formula (1-10) , 3-d] pyrimidinecarboxylic acid derivative.
- This step can be performed according to the method described in Tetrahedron, 1993, Vol. 49, No. 31, p. 6899.
- This reaction can be carried out in a solvent, and any solvent that does not harm the reaction can be used.
- the solvent include water; amide solvents such as N, N-dimethylformamide (DMF), N, N-dimethylacetamide (DMAC) and N-methylpyrrolidone (NMP); nitriles such as acetonitrile and propionitrile Alcohol solvents such as methanol, ethanol, propanol, and isopropanol; ether solvents such as getyl ether, diisopropyl ether, tetrahydrofuran (THF), dimethoxetane (DME), and 1,4-dioxane; dimethyl sulfoxide (DMSO); or any solvent which does not harm the reaction, such as a mixed solvent thereof, can be used.
- the target product can be obtained with good yield by performing the reaction at a temperature appropriately selected from the range of 0 ° C. to the solvent reflux temperature.
- each reactant may be used in an equimolar amount, but any of them may be used in excess.
- reaction product can be isolated by a conventional method and, if necessary, purified by recrystallization, silica gel column chromatography, or another operation. It can also be used for the next reaction without isolation.
- Step — 12 is to produce an acid chloride from a thieno [2,3-d] pyrimidinecarboxylic acid derivative (1-10) using thioyrc-mouth chloride, phosphorus oxychloride, phosphorus pentachloride, oxalyl chloride, etc.
- This is a step of producing a thieno [2,3-d] pyrimidine derivative represented by the general formula (1-11) by reacting with a compound represented by the general formula (XVII).
- the step of producing a thieno [2,3-d] pyrimidine derivative represented by the general formula (1-1-1) using an acid halide as a raw material is preferably performed in the presence of a base.
- Bases include triethylamine, disopropylethylamine, triptylamine, N-methylinoleforin, N, N-dimethylaniline (DMA), N, N-Jetylaniline, 41 t Chinole _N, N-Dimethyl ⁇ / aniline, pyridine, 4- (dimethinoleamino) pyridine (DMAP), picoline, noretidine, 1,5-diazabicyclo [5.4.0] pentane 5-ene
- Organic bases such as (DBU), 1,4-diazabicyclo [2.2.2] octane (DABCO) and imidazole can be used.
- the target product can be obtained in good yield by using 0.1 to 2.0 equivalents of the base with respect to the substrate.
- This reaction can be carried out in a solvent, and any solvent that does not harm the reaction can be used.
- the solvent include water; amide solvents such as N, N-dimethylformamide (DMF), N, N-dimethylacetamide (DMAC) and N-methylpyrrolidone (Picture P); and amide solvents such as acetonitrile and propionitrile.
- Tolyl solvents aromatic hydrocarbon solvents such as benzene, toluene, xylene, and benzene; aliphatic hydrocarbon solvents such as pentane, hexane, and octane; getyl ether, diisopropyl ether, tetra Use ether solvents such as hydrofuran (THF), dimethoxyethane (DME), and 1,4-dioxane; dimethyl sulfoxide (DMSO); or a mixture of these solvents as long as they do not harm the reaction. be able to.
- aromatic hydrocarbon solvents such as benzene, toluene, xylene, and benzene
- aliphatic hydrocarbon solvents such as pentane, hexane, and octane
- Use ether solvents such as hydrofuran (THF), dimethoxyethan
- the reaction can be carried out at a temperature appropriately selected from the range of the solvent reflux temperature from -78 to give the desired product in good yield.
- each reactant may be used in an equimolar amount, but any one of them may be used in excess.
- Step-13 is a thieno [2,3-d represented by the general formula (1-4)
- a pyrimidine derivative is reacted with a tin hydride compound represented by the general formula (XVIII) to produce a thieno [2,3-d] pyrimidine derivative (1-12).
- the solvent examples include water; aromatic hydrocarbon solvents such as benzene, toluene, and xylene; ether solvents such as diethyl ether, diisopropyl ether, tetrahydrofuran (THF), methoxetane (DME), and 1,4-dioxane; Halogenated hydrocarbon solvents such as chloroform, dichloromethane, carbon tetrachloride and the like; or solvents such as a mixed solvent thereof which do not harm the reaction can be used.
- aromatic hydrocarbon solvents such as benzene, toluene, and xylene
- ether solvents such as diethyl ether, diisopropyl ether, tetrahydrofuran (THF), methoxetane (DME), and 1,4-dioxane
- Halogenated hydrocarbon solvents such as chloroform, dichloromethane, carbon tetrachloride and the like
- the target product can be obtained with good yield by performing the reaction at a temperature appropriately selected from the range of 0 ° C. to the solvent reflux temperature.
- reaction product can be isolated by a conventional method and, if necessary, purified by recrystallization, silica gel column chromatography, or another operation. Manufacturing method 5
- Step-14 is a step of decarboxylating the thieno [2,3_d] pyrimidine derivative represented by the general formula (1-10) to obtain the thieno [2,3-d] represented by the general formula (1-13) This is a step of producing a pyrimidine derivative.
- This reaction can be carried out in a solvent, and any solvent that does not harm the reaction can be used.
- the solvent include water; amide solvents such as N, N-dimethylformamide (DMF), N, N-dimethylacetamide (DMAC) and N-methylpyrrolidone (NMP); and solvents such as acetonitrile and propionitrile.
- Nitrile solvents aromatic hydrocarbon solvents such as benzene, toluene, xylene, and benzene; aliphatic hydrocarbon solvents such as pentane, hexane, and octane; getyl ether, diisopropyl ether, tetrahydro Ether solvents such as furan (THF), dimethoxyethane (DME), and 1,4-dioxane; dimethyl sulfoxide (DMSO): or a solvent that does not hinder the reaction, such as a mixed solvent of these solvents can do.
- aromatic hydrocarbon solvents such as benzene, toluene, xylene, and benzene
- aliphatic hydrocarbon solvents such as pentane, hexane, and octane
- getyl ether, diisopropyl ether, tetrahydro Ether solvents such as furan (THF), dimethoxye
- the reaction is carried out at a temperature appropriately selected from the range of room temperature to the reflux temperature of the solvent to obtain a yield.
- the desired product can be obtained efficiently.
- reaction product can be isolated by a conventional method and, if necessary, purified by recrystallization, silica gel column chromatography, or another operation. It can also be used for the next reaction without isolation.
- step 15 the thieno [2,3-d] pyrimidine derivative represented by the general formula (1-13) is reacted with an oxidizing agent to oxidize the 1- and Z- or 3-position nitrogen atoms.
- This is a process for producing a thieno [2,3-d] pyrimidine derivative represented by the general formula (1-14) by reacting rilocyanide.
- This step can be performed according to the method described in Synthesis, 1984, page 681.
- the oxidizing agent used in this step include m-chloroperbenzoic acid and peracetic acid.
- the amount of the acid reagent can be appropriately selected and used within the range of equimolar to 5 times mol.
- This oxidation reaction can be carried out in a solvent, and any solvent that does not harm the reaction can be used.
- a solvent water; an aromatic hydrocarbon solvent such as toluene, benzene, and dichlorobenzene; a halogenated hydrocarbon solvent such as chloroform, dichloromethane, and carbon tetrachloride; or a mixed solvent thereof can be used. It can.
- the target product can be obtained with good yield by performing the reaction at a temperature appropriately selected from the range of 0 ° C. to the solvent reflux temperature.
- Bases include triethylamine, disopropylethylamine, triptylamine, N-methyloremorpholine, N, N-dimethylaniline (DMA), N, N-getinoleadiline, 4-t-butyl-1N, N —Dimethylaniline, pyridine, 4- (dimethylamino) pyridine
- This reaction can be carried out in a solvent, and any solvent that does not harm the reaction can be used.
- the solvent include water; amide solvents such as N, N-dimethylformamide (DMF), N, N-dimethylacetamide (DMAC) and N_methylpyrrolidone (NMP); nitriles such as acetonitrile and propionitrile Aromatic solvents such as benzene, toluene, xylene, and black benzene; aliphatic hydrocarbon solvents such as pentane, hexane, and octane; getyl ether, disopropyl ether, Ether solvents such as trahydrofuran (THF), dimethoxyethane (DME), and 1,4-dioxane; dimethyl sulfoxide (DMSO); or a solvent that does not harm the reaction, such as a mixed solvent thereof If you can use it.
- the reaction can be carried out at a temperature appropriately selected
- each reactant may be used in an equimolar amount, but any of them may be used in excess.
- reaction product can be isolated by a conventional method and, if necessary, purified by recrystallization, silica gel column chromatography, or another operation. It can also be used for the next reaction without isolation.
- R 11 represents an optionally substituted alkyl group or an optionally substituted Ariru group
- R 12 Represents an alkynole group.
- Step 16 is a step of acylating the aminothiophene derivative represented by the general formula (XIX) using an acid halide represented by the general formula (XX) to obtain a thiophene derivative represented by the general formula (XXI). This is the manufacturing process.
- Bases include triethylamine, diisopropylethylamine, tryptinoleamine, N-methylmorpholine,, N-dimethylaniline (DMA), N, N-getylaniline, 4-t-butylethyl N, N-dimethyl Tylaniline, pyridine, 4- (dimethylamino) pyridine (DMAP), picoline, lutidine, 1,5-diazabicyclo [5.4.0] indene-5-ene (DBU), 1,4-diazabicyclo [2.2.2. 2]
- Organic bases such as octane (DABCO) and imidazole can be used.
- This reaction can be carried out in a solvent, and any solvent that does not harm the reaction can be used.
- the solvent include water; amides such as N, N-dimethylformamide (DMF), N, N-dimethylacetamide (DMAC), and N-methylpyrrolidone (NMP) -Tolyl solvents such as acetonitrile and propionitrile; Aromatic hydrocarbon solvents such as benzene, toluene, xylene, and benzene; Aliphatic hydrocarbon solvents such as pentane, hexane, and octane; Ether solvents such as getyl ether, diisopropyl ether, tetrahydrofuran (THF), dimethoxyethane (DME), and 1,4-dioxane; dimethyl sulfoxide (DMSO); ethers such as ethyl acetate and methyl acetate Solvents: halogenated hydrocarbon solvents such as
- the target product can be obtained in good yield by performing the reaction at a temperature appropriately selected from the range of -78 ° C to the solvent reflux temperature.
- each reactant may be used in an equimolar amount, but any one of them may be used in excess.
- reaction product can be isolated by a conventional method and, if necessary, purified by recrystallization, silica gel column chromatography, or another operation. It can also be used for the next reaction without isolation.
- Step 17 is a step of producing a 4-hydroxythieno [2,3_d] pyrimidine derivative represented by the general formula (XXII) by cyclizing a thiophene derivative represented by the general formula (XXI). It is.
- This step is preferably performed in the presence of a base.
- the base include alkali metal bases such as sodium hydride, sodium hydride, sodium hydroxide, sodium hydroxide, sodium methoxide, sodium ethoxide, potassium-t-butoxide, triethylamine, diisopropylethylamine. , Triptyluamine, N-methylmorpholine, 1,5-diazabicyclo [5.4.0] indene 5-Dene (DBU), 1,4-diazabicik mouth [2.2.2] octane (DABCO), imidazole Etc. can be used.
- the target compound can be obtained in good yield by using 0.1 to 2.0 equivalents of the base relative to the substrate.
- This reaction can be carried out in a solvent, and any solvent that does not harm the reaction can be used.
- the solvent include water; amide solvents such as N, N-dimethylformamide (DMF), N, N-dimethylacetamide (DMAC) and N-methylpyrrolidone (NMP); nitriles such as acetonitrile and propionitrile Aromatic solvents such as benzene, toluene, xylene, and benzene; aliphatic hydrocarbon solvents such as pentane, hexane, and octane; getyl ether, disopropyl ether, Ether solvents such as trahydrofuran (THF), dimethoxyethane (DME) and 1,4-dioxane; dimethyl sulfoxide (DMSO); alcohol solvents such as methanol, ethanol and isopropanol (IPA); Or for the reaction of these mixed solvents Any solvent that does not cause harm can be
- the target product can be obtained with good yield by performing the reaction at a temperature appropriately selected from the range of 0 ° C. to the solvent reflux temperature.
- reaction product can be isolated by a conventional method and, if necessary, purified by recrystallization, silica gel column chromatography, or another operation. It can also be used for the next reaction without isolation.
- Step — 18 is carried out by halogenating a 4-hydroxythieno [2,3-d] pyrimidine derivative represented by the general formula (XXII) in the same manner as in Step 14, to obtain a compound represented by the general formula (I-11)
- This is a process for producing a thieno [2,3-d] pyrimidine derivative represented by 5).
- Step 19 is carried out by reacting a thieno [2,3_d] pyrimidine derivative represented by the general formula (1-15) with a mercaptan represented by the general formula (XXIII), followed by oxidation.
- This is a process for producing a thieno [2,3-d] pyrimidine derivative represented by the general formula (1-16).
- the reaction in the reaction with the mercaptans represented by the general formula (XXIII), the reaction can proceed with good yield by using a base.
- the base include alkali metal bases such as sodium hydride, hydrogenation power, sodium hydroxide, hydroxylation power, sodium carbonate, potassium carbonate, and organic bases such as triethylamine, diisopropylethylamine, and triptylamine.
- the target compound can be obtained in good yield by using 0.1 to 2.0 equivalents of the base with respect to the substrate.
- the target product can be obtained in good yield by performing the reaction at a temperature appropriately selected from the range of 0 to the solvent reflux temperature.
- each reactant may be used in an equimolar amount, but any one of them may be used in excess.
- reaction product can be isolated by a conventional method and, if necessary, purified by recrystallization, silica gel column chromatography, or another operation. It can also be used for the next reaction without isolation.
- an oxidizing agent such as m-chloroperbenzoic acid and peracetic acid can be used.
- the amount of the oxidizing agent to be used can be appropriately selected and used within a range of equimolar to 5 times mol.
- This acid reaction can also be carried out in a solvent, and any solvent which does not harm the reaction can be used.
- a solvent water; an aromatic hydrocarbon solvent such as toluene, benzene, and dichlorobenzene; a halogenated hydrocarbon solvent such as chloroform, dichloromethane, and carbon tetrachloride; or a mixed solvent thereof can be used.
- the target product can be obtained with good yield by performing the reaction at a temperature appropriately selected from the range of 0 ° C. to the solvent reflux temperature.
- the reaction product can be isolated by a conventional method and, if necessary, purified by recrystallization, silica gel column chromatography, etc. It can also be used for the next reaction without isolation.
- step 20 the thieno [2,3_d] pyrimidine derivative represented by the general formula (1-16) is reacted with the compound represented by the general formula (XXIV), and represented by the general formula (1_1 7) This is a process for producing a cheno [2,3-d] pyrimidine derivative.
- This step is preferably performed in the presence of a base.
- the base include sodium hydride, hydrogenation power, sodium carbonate, carbonation power, sodium hydroxide, hydroxylation power, sodium methoxide, sodium methoxide, potassium tert-oxide and the like.
- Metal base triethylamine, diisopropylethylamine, triptylamine, N-methylmorpholine, pyridine, 4- (dimethylamino) pyridine (DMAP), picoline, noretidine, 1,5-diazabicyclo [5.4.0]
- Organic bases such as dendec-5-ene (DBU), 1,4-diazabicyclo [2.2.2] octane (DABCO) and imidazole can be used.
- the target compound can be obtained in good yield by using the base in an amount of from 0 :! to 2.0 equivalents to the substrate.
- This reaction can be carried out in a solvent, and any solvent that does not harm the reaction can be used.
- the solvent include water; amide solvents such as N, N-dimethylformamide (DMF), N, N-dimethylacetoamide (DMAC) and N-methylpyrrolidone (NMP); nitriles such as acetonitrile and propionitrile Aromatic solvents such as benzene, toluene, xylene, and benzene; aliphatic hydrocarbon solvents such as pentane, hexane, and octane; getyl ether, diisopropyl ether, tetrahydrofuran (THF ), Dimethoxetane (DME), 1,4-dioxane, etc .; ether solvents; dimethyl sulfoxide (DMSO), methanol, ethanol, isopropanol (IPA), etc .; Any solvent that does not harm the reaction can be used
- the reaction can be carried out at a temperature appropriately selected from the range of from 0 to the solvent reflux temperature to obtain the desired product with good yield.
- each reactant may be used in an equimolar amount, but any one of them may be used in excess.
- reaction product can be isolated by a conventional method and, if necessary, purified by recrystallization, silica gel column chromatography, or another operation. Manufacturing method 1 7
- Step 21 is a step of reacting an aminothiophene derivative represented by the general formula (XXV) with potassium cyanate or sodium cyanate to produce a ureidothiophene derivative represented by the general formula (XXVI). .
- This reaction can be carried out in a solvent, and any solvent that does not harm the reaction can be used.
- the solvent include water; amide solvents such as, -dimethylformamide (DMF), N, N-dimethylacetoamide (DMAC), and N-methylpyrrolidone (NMP); nitrile solvents such as acetonitrile and propionitrile Solvents; Aromatic hydrocarbon solvents such as benzene, toluene, xylene, and benzene; aliphatic hydrocarbon solvents such as pentane, hexane, and octane; getyl ether, diisopropyl ether, and tetrahydrofuran (THF), dimethoxyethane (DME), 1,4-dioxane, etc .; ether solvents; dimethyl sulfoxide (DMSO); acetic acid; alcohol solvents, such as methanol, ethanol, isopropanol (IPA);
- the target product can be obtained with good yield by performing the reaction at a temperature appropriately selected from the range of 0 to the solvent reflux temperature.
- each reactant may be used in an equimolar amount, but any one of them may be used in excess.
- reaction product can be isolated by a conventional method and, if necessary, purified by recrystallization, silica gel column chromatography, or another operation. It can also be used for the next reaction without isolation.
- Step-22 is carried out from the ureidothiophene derivative represented by the general formula (XXVI) by the same operation as in the above-mentioned step 117, to give the 2,4-dihydroxythieno represented by the general formula (XXVII) [2,3- d]
- This is a step of producing a pyrimidine derivative.
- step 23 the 2,4-dihydroxythieno [2,3-d] pyrimidine derivative represented by the general formula (XXVII) is halogenated by the same operation as in step 14 to obtain a compound represented by the general formula (III) For producing 2,4-dihalogenothieno [2,3-d] pyrimidine derivatives represented by It is.
- Step-24 and step-26 are carried out from the halogeno thieno [2,3-d] pyrimidine derivative represented by the general formula (III) or (1-18) by the same operation as in the above-mentioned step 119 by the general formula
- This is a process for producing a thieno [2,3_d] pyrimidine derivative represented by (XXVIII) or (1-19).
- Step-1 25 and step-27 are carried out from the thieno [2,3-d] pyrimidine derivative represented by the general formula (XXVIII) or (1-19) by the same operation as in the above-mentioned step-20, by the same method as in the above-mentioned step-20.
- This is a process for producing a thieno [2,3-d] pyrimidine derivative represented by I-18) or (1-20).
- Step-28 comprises a coupling reaction of a 4-halogenothieno [2,3-d] pyrimidine derivative represented by the general formula (XXIX) with a boronic acid represented by the general formula (XXX), This is a process for producing a thieno [2,3-d] pyrimidine derivative represented by the formula (1-21).
- Tetrahedron Lett., 19 "years, 40th Certificates, fifth No.1, can be carried out according to the method described in pages 9005.
- This step can be carried out in the presence of a catalyst such as triphenylphenylphosphine palladium with a good yield, and the amount of the palladium catalyst used is 4-halogenothieno [2,3-d] represented by the general formula (XXIX).
- a catalyst such as triphenylphenylphosphine palladium with a good yield
- the amount of the palladium catalyst used is 4-halogenothieno [2,3-d] represented by the general formula (XXIX).
- the pyrimidine derivative may be appropriately selected and used in the range of 0.0001 to 0.1 times the mole of the pyrimidine derivative.
- alkali metal bases such as sodium carbonate and potassium carbonate, triethylamine, diisopropylethylamine, triptylamine, N-methylmonorephorin, N, N-dimethylaniline (DMA), N, N-dimethylethylamine, 4-t Butynole N, N-Dimethinoreayurin, Pyridine, 4- (Dimethylamino) pyridin (DMAP), Picoline, Lutidine, 1,5-Diazabicyclo [5.4.0] Pendene 5-Dene (DBU), 1, Organic bases such as 4-diazabicyclo [2.2.2] octane (DAB CO) and imidazole can be used.
- the base is 0.1 to 2.0 relative to the substrate. By using an equivalent amount, the desired product can be obtained in good yield.
- This reaction can be carried out in a solvent, and any solvent that does not harm the reaction can be used.
- the solvent include water; aromatic hydrocarbon solvents such as benzene, toluene, xylene, and chlorobenzene; getyl ether, diisopropyl ether, tetrahydrofuran (THF), dimethoxyethane (DME), Ether solvents such as 4-dioxane; halogenated hydrocarbon solvents such as dichloromethane and chloroform; and solvents such as a mixed solvent thereof which do not hinder the reaction can be used.
- the target product can be obtained with good yield by performing the reaction at a temperature appropriately selected from the range of 0 ° C. to the solvent reflux temperature.
- each reactant may be used in an equimolar amount, but any one of them may be used in excess.
- reaction product After completion of the reaction, the reaction product can be isolated by a conventional method and, if necessary, purified by recrystallization, silica gel column chromatography, or another operation. Manufacturing method— 9
- Step-29 the aminothiophene derivative represented by the general formula (XI) is reacted with potassium cyanate or sodium cyanate. This is a step of producing a ureidothiophene derivative represented by the following formula: Where the general formula (VI)
- R 1 and R 2 are the same as above, and W represents an aryl group which may be substituted.
- the peridothiophene derivative represented by the formula is a novel compound.
- step 30 the ureidothiophene derivative represented by the general formula (XXXI) Step-1
- This is a step of producing a 2-hydroxythieno [2: 3-d] pyrimidine derivative represented by the general formula (XII) by the same operation as in Step 17.
- step _31 the aminothiophene derivative represented by the general formula (XXXII) is reacted with potassium cyanate or sodium cyanate, and the same operation as in the above-mentioned step 1-21 is carried out.
- This is a step of producing a ureidothiophene derivative represented by
- Step-1 32 is carried out from the ureidothiophene derivative represented by the general formula (XXXIII) by the same operation as in the above-mentioned step 17 to 2,4-dihydroxythieno represented by the general formula (XXXIV) [3, 2-d] This is a step of producing a pyrimidine derivative.
- step 1-3 the 2,4-dihydroxythieno [3,2-d] pyrimidine derivative represented by the general formula (XXXIV) is halogenated by the same operation as in the step 1-4 to give the general formula (XXXV)
- Step 34 the 2,4-dihalogenothieno [3,2-d] pyrimidine derivative (XXXV) is subjected to the same operation as in Step 28 described above, to give the 2-halogeno thieno represented by the general formula (1-22). 3, 2—d] This is a step of producing a pyrimidine derivative.
- step-15 the 2-halogenothieno [3,2-d] pyrimidine derivative represented by the general formula (1-22) is converted into the compound represented by the general formula (1-23) by the same operation as in the step-15.
- This is the process for producing the thieno [3,2-d] pyrimidine derivative represented. 4.
- the compound represented by the above general formula (I) may be applied as it is, but usually, an appropriate scavenger is used, and a wettable powder, a granule, or Used in the form of preparations such as L and flowables.
- the content of the compound represented by the above general formula (I) in the preparation varies depending on the form of the preparation, but is generally, for example, 1 to 90% by weight for a wettable powder. 0.1-30% by weight for granules, 1-50% by weight for emulsions, and 5-50% by weight for flowables are appropriate.
- the preparation containing the compound represented by the above general formula (I) is applied as it is, or diluted with water, depending on its form.
- scavenger used in the preparation of the preparation examples include solid carriers such as dextrin, bentonite, ternolec, diatomaceous earth, white carbon, and starch; water, alcohols (eg, methanol, ethanol, propanol, butanol, and ethylene glycol). ), Ketones (acetone, methyl ethyl ketone, cyclohexanone, isophorone, etc.), ethers
- a preparation containing the compound represented by the above general formula (I) When a preparation containing the compound represented by the above general formula (I) is diluted with water and applied, it is spread in a spray liquid in order to improve adhesion and spreadability, and to enhance the herbicidal effect.
- An auxiliary agent such as an agent may be added.
- Surfactants the above-mentioned nonionic surfactants, cationic surfactants, anionic surfactants, amphoteric surfactants IJ), paraffins, Examples include polyacetate bur, polyacrylate, ethylene glycol, polyethylene glycol, cup oil (mineral oil, animal and vegetable oil, etc.), and liquid fertilizer. If necessary, two or more of these scavengers may be used simultaneously.
- the amount of adjuvant used depends on the type, but usually 0.01 to 5% by weight is added to the spray liquid. It is appropriate to add. In addition, depending on the type of scavenger, it is possible to preliminarily add soy sauce as a component in the preparation.
- the application rate of the compound represented by the above general formula (I) varies depending on conditions such as the structure of the compound, the target weed, the treatment time, the treatment method, and the properties of the soil.
- the effective component amount per hectare is as follows. A range of 2 to 2000 grams, preferably 5 to 1000 grams is appropriate.
- weeds to which the herbicide of the present invention is applied in the field, for example, Shiroza, Akaza, Inutade, Hartade, Inubu, Aobu, Hakobe, Hotokenoza, Ichibi, Onamimi, Manorebaasagao, Kosenasaagao, Seiyokarashina
- broadleaf varieties such as millet, oroshagiku and kosendangusa
- narrowleaf weeds such as mehishiba, ohishiba, chinubi and enokorogosa.
- broadleaf weeds such as Kikasigusa, Azena, Konagi, Apnome, Mizohakobe, Heramodaka, Taishimodaka, and Perica
- narrow-leaf weeds such as Tainubie, Tamagayari, Firefly, and Mizugayari are listed.
- the herbicide of the present invention can control the above-mentioned weeds in upland fields and paddy fields by any of soil treatment, foliage treatment and flooding treatment. Further, the herbicide of the present invention has little effect on cultivated crops such as corn, wheat, rye, rice, soybean and the like in both soil treatment and foliage treatment. It can be used as an agent.
- the herbicide of the present invention can be applied in combination with other pesticides such as insecticides, fungicides, plant growth regulators, and fertilizers used in the same field. In addition, it can be mixed with other herbicides to stabilize the herbicidal effect.
- pesticides such as insecticides, fungicides, plant growth regulators, and fertilizers used in the same field.
- it can be mixed with other herbicides to stabilize the herbicidal effect.
- each of the two preparations may be mixed at the time of application, but the preparation should be applied as a preparation containing both in advance. Is also good.
- Examples of herbicides that can be suitably mixed and applied with the compound represented by the general formula (I) include the following.
- Etinole 0 [5— [2-Chloro-41- (trifluoromethyl) phenoxy] —2-nitrobenzyl] —DL—ratate
- Etinole 2 _ (4-black mouth _ 6-methoxypyrimidine-1 2_.
- Methynole 2- (4,6-dimethoxypyrimidine-1-ylcarbamoylsulfamoylmethinolate) benzoate,
- Methynole 2 [4-ethoxy 6— (methinoleamino) -1-1,3,5-triazine-1—2-inolecanoleva Moinoresnorefamoinole] benzoate
- Triazine herbicides are Triazine herbicides:
- Ammonia gas was blown into a four-necked eggplant flask cooled in a dry ice-aceton bath, and liquid ammonia (87 g) was taken.
- Sodium amide (8.26 g , 0.212 mol) was added to the flask, and then acetonitrile ( 8 .69 g, 0.212 mol) in toluene (lOraL) and 4-fluoro-3- (trifluoromethyl) ethyl benzoate (25.0 g, 0.106raol) in toluene (lOmL), and added at -70 °
- the mixture was stirred at C for 1 hour. While returning the reaction solution to room temperature, ammonia gas was released out of the system.
- Acetonitrile (4.02 g, 97.8 t) was added to a suspension of sodium hydride (3.91 g, 97.8 t) in THF (50 raL), and the mixture was heated at 70 ° C for 1 minute.
- the reaction solution was returned to room temperature, and a 3 ⁇ 4 ⁇ (20111) solution of methyl 3- (trifluoromethyl) benzoate (10.0 g, 48.9%) was added dropwise, followed by heating and stirring at 60 ° C for 6 hours.
- the solvent was distilled off, the residue was poured into water, and this was extracted with ethyl acetate. The obtained extract was washed with water and saturated saline, and then the solvent was distilled off.
- reaction solution was poured into water, extracted with ethyl acetate, and the extract was washed with water and saturated saline, and then the solvent was distilled off.
- the residue was purified using a silica gel column (Kieselgel60, 30% AcOEt-Hex, manufactured by MERCK), and 2- (isopropyl (Noresnoreffoninoleoxy) -6-methinole-4- [3- (trifluoromethyl) phenyl] cheno [2,3-d] pyrimidine (60.4 mg, 15%) was obtained.
- Methylmercaptan sodium salt (0.64 g, 9.13 mraol) is suspended in THF (20 mL), and 2-chloro-6-methyl-4- [4- (trifluoromethyl) phenyl] thieno [2,3-d]
- THF 20 mL
- 2-chloro-6-methyl-4- [4- (trifluoromethyl) phenyl] thieno [2,3-d] A solution of pyrimidine (1.5 g, 4.57 mmol) in THF (5 mL) was added dropwise at room temperature, and the mixture was refluxed for 7 hours. After completion of the reaction, the reaction solution was poured into aqueous sodium bicarbonate, extracted with ethyl acetate, the extract was washed with water and saturated saline, and then the solvent was distilled off.
- the residue was purified with a silica gel column (Kieselgel60, manufactured by MERCK, 20% AcOEt-Hex to Ac0Et only), and 6-methyl-2- (methyls Rufonyl) -1-4- [4- (Trifluoromethyl) phenyl] thieno [2,3-d] pyrimidine (0.70 g, 64%) and 6-methynole-2-methylsulfinyl-4-1- [4- ( Trifluoromethyl) phenyl] thieno [2,3-d] pyrimidine (0.20 g, 19%) was obtained.
- 6-Methynolee 2_ [4- (Trinoleolomethynole) phenyl] —4- [3-L) phenyl] Thieno [2,3-d] pyrimidine (Compound No.6-18)
- reaction solution was poured into water, extracted with ethyl acetate, and the extract was washed with water and saturated saline, and then the solvent was distilled off.
- the residue was purified by silica gel column (Kieselgel60 N 10% Ac0Et-Hex manufactured by MERCK) to give 6-methinole-2- [4- (trifluoromethyl) phenyl] -4- [3- (trifluoromethyl) phenyl.
- Thieno [2,3-d] pyrimidine (0.22 g, 54%).
- 6-Methinole 4- [3- (Trifnoroleolomethinole) phenyl] Thieno [2,3-d] pyrimidine-2-carboxylic acid (0.40 g, 1.18 t ol) and thiol chloride (2 mL) ) was added, and the mixture was heated and stirred at 80 ° C for 1 hour. After completion of the reaction, the reaction solution was distilled off, and half of the obtained residue was added dropwise to a cooled mixed solution of ethanol (lOraL) and triethylamine (0.5raL).
- reaction solution was poured into water, extracted with ethyl acetate, and the extract was washed with water and saturated saline, and then the solvent was distilled off.
- the residue was purified by silica gel (Kieselgel60, 10% AcOEt-Hex manufactured by MERCK), and 6-methyl-4- [3- (trifluoromethyl) phenyl] thieno [2,3-d] pyrimidine- 2-Ethyl carboxylate (41.2 mg) was obtained.
- ol (ol) 3- (trifluoromethyl) phenol (0.27 g, 1.68 benzyl) and stirred at room temperature for 1.5 hours.
- the reaction solution was poured into water, extracted with ethyl acetate, and the extract was washed with water and saturated saline, and then the solvent was distilled off.
- reaction solution was poured into water, extracted with ethyl acetate, the extract was washed with water and saturated saline, and the solvent was distilled off.
- the residue was purified by silica gel column (Kieselgel60, 10% Ac0Et-Hex, MERCK), and 2-chloro-6-methyl-4- [3- (trifluoromethyl) phenyl] thieno [3,2-d] pyrimidine (1.33 g, 89%).
- Trim (0.10 g, 2.50 g ol) was added to the mixture, and the mixture was stirred at room temperature for 0.5 hour. The mixture was cooled with ice water, and the mixture was cooled with 6-methyl 4- [3- (trifnoroleolomethyl) phenyl] -2. A solution of -chlorocheno [3,2-d] pyrimidine (0.40 g, 1.22 mmol) in THF (5 mL) was added dropwise. After returning the reaction solution to room temperature, it was heated and stirred at 60 ° C. for 2 hours. After the completion of the reaction, the solvent was distilled off, and the obtained residue was dissolved in ethyl acetate.
- Residue is purified by silica gel column (MERCK Purified by Kieselgel 60, 20-40% AcOEt-Hex) to obtain a total of 5-methyl-2-[(4,4,4-trifluorobutyryl) amino] thiophene-3-carboxamide (6.58 g, 37%) Was.
- 6-Methinoles 4- 4-Methinoles-noleshoninole _2- (3,3,3-Trifluoropropyl) thieno [2,3-d] pyrimidine
- 6-Methinole-4 Metalethio-2- (3,3,3_Triphnoreo-propinole) thieno [2,3-d] pyrimidine (l. 60 g , 5.4 ⁇ ol) salt methylene (20raL)
- m-chloroperbenzoic acid (2.83 g, 16.4 orl ol) was added and stirred at room temperature for 1 day.
- the precipitated crystals were separated by filtration, the filtrate was poured into water, extracted with ethyl acetate, and the extract was washed with water and saturated saline. Then the solvent was distilled off. The residue was purified by silica gel column (MERCK Co.
- Is a hexyl group “Ph” is a phenyl group, “P y” is a pyridyl group, “Ac” is an acetyl group, “Ts” is a paratoluenesulfonyl group, “n ⁇ ” is normal, “i-” represents iso, “t-” represents tertiary, and “c-” represents an alicyclic hydrocarbon group. Also during the six tables X 1 column, "one” represents a single bond.
- a mixed solution consisting of 10 parts of the compounds described in Tables 1 to 6 was composed of 40 parts of an aromatic hydrocarbon solvent, Solvesso 200 (trade name, Exxon Chemical Co., Ltd.) and 40 parts of N, N-dimethylacetamide. After dissolving in a solvent, 10 parts of a polyoxyethylene surfactant (Solpol 3 ⁇ (trade name, Toho Chemical Co.)) was added and dissolved to obtain an emulsion containing 10% of the active ingredient.
- Solvesso 200 trade name, Exxon Chemical Co., Ltd.
- N, N-dimethylacetamide N, N-dimethylacetamide
- Weeding rate (%) (11) X 00 The weeding rate was calculated from the above-ground live weight of weeds in the untreated plot, and expressed as the weeding efficiency coefficient according to the following criteria. Weeding efficiency coefficient Weeding rate (%)
- Paddy soil of alluvial clay loam was filled into a resin vat with an area of 20 O cm 2 , and after fertilization, soybean sprouts, kikasigusa and fireflies were sown, and the soil was uniformly covered to a depth of 3 cm. After that, the cultivation management was continued in the greenhouse, and when the growing leaf age of the test weed reached the cotyledon stage to the first leaf stage, the wettable powder obtained in Formulation Example 1 was diluted with water to adjust the amount of the active ingredient. A predetermined amount was uniformly dropped using a pipette so that the amount was 10 g per 1 are. After that, the cultivation management was continued in the greenhouse, and the herbicidal effect was investigated on the 28th day after the chemical treatment. The results are shown in Table 9 (the compound numbers in Table 9 correspond to the compound numbers in Tables 1 to 6).
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03753959A EP1544202A4 (en) | 2002-09-26 | 2003-09-26 | NEW HERBICIDES, THEIR USE, NEW THIENOPYRIMIDINE DERIVATIVES, INTERMEDIATE PRODUCTS DAF R AND METHOD FOR THE PRODUCTION THEREOF |
AU2003272898A AU2003272898B2 (en) | 2002-09-26 | 2003-09-26 | Novel herbicides, usage thereof, novel thienopyrimidine derivatives, intermediates of the same, and process for production thereof |
US10/529,474 US20070010402A1 (en) | 2002-09-26 | 2003-09-26 | Novel herbicides, usage thereof, novel thienopyrimidine derivatives, intermediates of the same, and process for production thereof |
CA002500207A CA2500207A1 (en) | 2002-09-26 | 2003-09-26 | Novel herbicide, method of using the same, novel substituted thienopyrimidine derivative and intermediate thereof, and process for producing the same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002281271 | 2002-09-26 | ||
JP2002-281271 | 2002-09-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004029060A1 true WO2004029060A1 (ja) | 2004-04-08 |
Family
ID=32040508
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2003/012356 WO2004029060A1 (ja) | 2002-09-26 | 2003-09-26 | 新規除草剤、その使用方法、新規チエノピリミジン誘導体及びその中間体並びにその製造方法 |
Country Status (7)
Country | Link |
---|---|
US (1) | US20070010402A1 (ja) |
EP (1) | EP1544202A4 (ja) |
AR (1) | AR044743A1 (ja) |
AU (1) | AU2003272898B2 (ja) |
CA (1) | CA2500207A1 (ja) |
TW (1) | TW200410975A (ja) |
WO (1) | WO2004029060A1 (ja) |
Cited By (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006046485A1 (ja) * | 2004-10-25 | 2006-05-04 | Nihon Nohyaku Co., Ltd. | 畑作用除草剤組成物及び防除方法 |
US7071190B2 (en) | 2002-02-15 | 2006-07-04 | Rigel Pharmaceuticals, Inc. | Inhibitors to tubulin polymerization |
US7601725B2 (en) | 2004-07-16 | 2009-10-13 | Sunesis Pharmaceuticals, Inc. | Thienopyrimidines useful as Aurora kinase inhibitors |
WO2013040021A1 (en) | 2011-09-13 | 2013-03-21 | Monsanto Technology Llc | Methods and compositions for weed control |
WO2013040117A1 (en) | 2011-09-13 | 2013-03-21 | Monsanto Technology Llc | Methods and compositions for weed control |
WO2013039990A1 (en) | 2011-09-13 | 2013-03-21 | Monsanto Technology Llc | Methods and compositions for weed control |
US8691813B2 (en) | 2008-11-28 | 2014-04-08 | Janssen Pharmaceuticals, Inc. | Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors |
US8691849B2 (en) | 2008-09-02 | 2014-04-08 | Janssen Pharmaceuticals, Inc. | 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors |
US8697689B2 (en) | 2008-10-16 | 2014-04-15 | Janssen Pharmaceuticals, Inc. | Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors |
US8722894B2 (en) | 2007-09-14 | 2014-05-13 | Janssen Pharmaceuticals, Inc. | 1,3-disubstituted-4-phenyl-1H-pyridin-2-ones |
US8748621B2 (en) | 2007-09-14 | 2014-06-10 | Janssen Pharmaceuticals, Inc. | 1,3-disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones |
US8785486B2 (en) | 2007-11-14 | 2014-07-22 | Janssen Pharmaceuticals, Inc. | Imidazo[1,2-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
US8841323B2 (en) | 2006-03-15 | 2014-09-23 | Janssen Pharmaceuticals, Inc. | 1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors |
WO2014151255A1 (en) | 2013-03-15 | 2014-09-25 | Monsanto Technology Llc | Methods and compositions for weed control |
US8906939B2 (en) | 2007-03-07 | 2014-12-09 | Janssen Pharmaceuticals, Inc. | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
US8937060B2 (en) | 2009-05-12 | 2015-01-20 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders |
US8946205B2 (en) | 2009-05-12 | 2015-02-03 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
US8993591B2 (en) | 2010-11-08 | 2015-03-31 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors |
US9012448B2 (en) | 2010-11-08 | 2015-04-21 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors |
US9067891B2 (en) | 2007-03-07 | 2015-06-30 | Janssen Pharmaceuticals, Inc. | 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mGluR2-receptors |
US9085577B2 (en) | 2009-05-12 | 2015-07-21 | Janssen Pharmaceuticals, Inc. | 7-aryl-1,2,4-triazolo[4,3-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
WO2015108982A2 (en) | 2014-01-15 | 2015-07-23 | Monsanto Technology Llc | Methods and compositions for weed control using epsps polynucleotides |
US9114138B2 (en) | 2007-09-14 | 2015-08-25 | Janssen Pharmaceuticals, Inc. | 1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′] bipyridinyl-2′-ones |
US9121022B2 (en) | 2010-03-08 | 2015-09-01 | Monsanto Technology Llc | Method for controlling herbicide-resistant plants |
US9271967B2 (en) | 2010-11-08 | 2016-03-01 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
US9416363B2 (en) | 2011-09-13 | 2016-08-16 | Monsanto Technology Llc | Methods and compositions for weed control |
US9422558B2 (en) | 2011-09-13 | 2016-08-23 | Monsanto Technology Llc | Methods and compositions for weed control |
US9422557B2 (en) | 2011-09-13 | 2016-08-23 | Monsanto Technology Llc | Methods and compositions for weed control |
US9540642B2 (en) | 2013-11-04 | 2017-01-10 | The United States Of America, As Represented By The Secretary Of Agriculture | Compositions and methods for controlling arthropod parasite and pest infestations |
US9604994B2 (en) | 2011-11-23 | 2017-03-28 | Cancer Research Technology Limited | Thienopyrimidine inhibitors of atypical protein kinase C |
US9708315B2 (en) | 2013-09-06 | 2017-07-18 | Janssen Pharmaceutica Nv | 1,2,4-triazolo[4,3-a]pyridine compounds and their use as positive allosteric modulators of MGLUR2 receptors |
US9777288B2 (en) | 2013-07-19 | 2017-10-03 | Monsanto Technology Llc | Compositions and methods for controlling leptinotarsa |
US9850496B2 (en) | 2013-07-19 | 2017-12-26 | Monsanto Technology Llc | Compositions and methods for controlling Leptinotarsa |
US10041068B2 (en) | 2013-01-01 | 2018-08-07 | A. B. Seeds Ltd. | Isolated dsRNA molecules and methods of using same for silencing target molecules of interest |
US10106542B2 (en) | 2013-06-04 | 2018-10-23 | Janssen Pharmaceutica Nv | Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of mGluR2 receptors |
US10240162B2 (en) | 2012-05-24 | 2019-03-26 | A.B. Seeds Ltd. | Compositions and methods for silencing gene expression |
US10378012B2 (en) | 2014-07-29 | 2019-08-13 | Monsanto Technology Llc | Compositions and methods for controlling insect pests |
US10537573B2 (en) | 2014-01-21 | 2020-01-21 | Janssen Pharmaceutica Nv | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
US10557138B2 (en) | 2013-12-10 | 2020-02-11 | Beeologics, Inc. | Compositions and methods for virus control in Varroa mite and bees |
US10612019B2 (en) | 2013-03-13 | 2020-04-07 | Monsanto Technology Llc | Methods and compositions for weed control |
US10609930B2 (en) | 2013-03-13 | 2020-04-07 | Monsanto Technology Llc | Methods and compositions for weed control |
US10655136B2 (en) | 2015-06-03 | 2020-05-19 | Monsanto Technology Llc | Methods and compositions for introducing nucleic acids into plants |
US10683505B2 (en) | 2013-01-01 | 2020-06-16 | Monsanto Technology Llc | Methods of introducing dsRNA to plant seeds for modulating gene expression |
US10760086B2 (en) | 2011-09-13 | 2020-09-01 | Monsanto Technology Llc | Methods and compositions for weed control |
US10801028B2 (en) | 2009-10-14 | 2020-10-13 | Beeologics Inc. | Compositions for controlling Varroa mites in bees |
US10806146B2 (en) | 2011-09-13 | 2020-10-20 | Monsanto Technology Llc | Methods and compositions for weed control |
US10808249B2 (en) | 2011-09-13 | 2020-10-20 | Monsanto Technology Llc | Methods and compositions for weed control |
US10829828B2 (en) | 2011-09-13 | 2020-11-10 | Monsanto Technology Llc | Methods and compositions for weed control |
US10883103B2 (en) | 2015-06-02 | 2021-01-05 | Monsanto Technology Llc | Compositions and methods for delivery of a polynucleotide into a plant |
US10888579B2 (en) | 2007-11-07 | 2021-01-12 | Beeologics Inc. | Compositions for conferring tolerance to viral disease in social insects, and the use thereof |
US10968449B2 (en) | 2015-01-22 | 2021-04-06 | Monsanto Technology Llc | Compositions and methods for controlling Leptinotarsa |
US10988764B2 (en) | 2014-06-23 | 2021-04-27 | Monsanto Technology Llc | Compositions and methods for regulating gene expression via RNA interference |
US11091770B2 (en) | 2014-04-01 | 2021-08-17 | Monsanto Technology Llc | Compositions and methods for controlling insect pests |
US11369606B2 (en) | 2014-01-21 | 2022-06-28 | Janssen Pharmaceutica Nv | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
US11807857B2 (en) | 2014-06-25 | 2023-11-07 | Monsanto Technology Llc | Methods and compositions for delivering nucleic acids to plant cells and regulating gene expression |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008092860A1 (en) * | 2007-01-30 | 2008-08-07 | Janssen Pharmaceutica N.V. | Bicyclic derivatives as ep4 agonists |
WO2008092862A1 (en) * | 2007-01-30 | 2008-08-07 | Janssen Pharmaceutica N.V. | Bicyclic derivatives as ep4 agonists |
WO2008092861A1 (en) * | 2007-01-30 | 2008-08-07 | Janssen Pharmaceutica N.V. | Bicyclic derivatives as ep4 agonists |
BRPI0912546A2 (pt) * | 2008-05-13 | 2016-10-18 | Boehringer Ingelheim Int | síntese de di-hidrotieno[3,2-d]-pirimidino dióis e pirimidino dióis similares. |
UA113831C2 (xx) | 2008-07-31 | 2017-03-27 | Способи і проміжні сполуки для одержання підсилювачів солодкого смаку | |
CN103556174B (zh) * | 2013-10-21 | 2016-06-01 | 哈尔滨理工大学 | 一种4-氯-1-甲基-3-乙基-5-吡唑羧酸乙酯的合成方法 |
CN112703193A (zh) | 2018-08-07 | 2021-04-23 | 弗门尼舍公司 | 5-取代的4-氨基-1H-苯并[c][1,2,6]噻二嗪2,2-二氧化物及其制剂和用途 |
US20230028441A1 (en) * | 2019-10-09 | 2023-01-26 | Bayer Aktiengesellschaft | Novel heteroaryl-triazole compounds as pesticides |
Citations (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4196207A (en) * | 1977-05-23 | 1980-04-01 | Ici Australia Limited | Process for controlling eradicating or preventing infestations of animals by Ixodid ticks |
GB1570494A (en) * | 1975-11-28 | 1980-07-02 | Ici Ltd | Thienopyrimidine derivatives and their use as pesticides |
EP0082023A2 (en) * | 1981-12-16 | 1983-06-22 | Sankyo Company Limited | Thienopyrimidine derivatives, their preparation and their medical use |
EP0202538A1 (de) * | 1985-05-17 | 1986-11-26 | Bayer Ag | Leistungsfördernde Mittel |
EP0404356A1 (en) * | 1989-05-30 | 1990-12-27 | Smithkline Beecham Intercredit B.V. | Substituted thienopyrimidine derivatives, their preparation, pharmaceutical compositions and medical use |
JPH0578721A (ja) * | 1991-09-19 | 1993-03-30 | Nippon Steel Corp | 溶融還元の操業方法 |
WO1993017021A1 (en) * | 1992-02-19 | 1993-09-02 | Pfizer, Inc. | Heterocyclic compounds for enhancing antitumor activity |
EP0579424A1 (en) * | 1992-07-17 | 1994-01-19 | Rohm And Haas Company | 2-substituted pyrimidines and herbicidal use thereof |
WO1994008975A1 (en) * | 1992-10-16 | 1994-04-28 | Nippon Soda Co., Ltd. | Pyrimidine derivative |
WO1998006722A1 (de) * | 1996-08-12 | 1998-02-19 | Merck Patent Gmbh | Thienopyrimidine |
WO1998017668A1 (de) * | 1996-10-24 | 1998-04-30 | Merck Patent Gmbh | Thienopyrimidine mit pde v inhibierender wirkung |
EP0899263A2 (en) * | 1997-08-13 | 1999-03-03 | Fujirebio Inc. | Fused pyrimidine derivatives and medicaments thereof for a blood oxygen partial pressure amelioration |
US5948911A (en) * | 1998-11-20 | 1999-09-07 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure to thienopyrimidine derivatives |
WO2000027812A1 (de) * | 1998-11-11 | 2000-05-18 | Bayer Aktiengesellschaft | Phenyl-substituierte zyklische enaminone |
US6133271A (en) * | 1998-11-19 | 2000-10-17 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives |
WO2001002409A1 (en) * | 1999-07-01 | 2001-01-11 | Vernalis Research Limited | Thieno- and furopyrimidine derivatives as a2a-receptor antagonists |
WO2001032632A2 (en) * | 1999-11-01 | 2001-05-10 | Eli Lilly And Company | Pharmaceutically active 4-substituted pyrimidine derivatives |
WO2001040202A1 (de) * | 1999-12-02 | 2001-06-07 | Bayer Aktiengesellschaft | (hetero)aryl-substituierte heterozyklische enaminone, deren herstellung und deren verwendung als herbizide, akarizide und insektizide |
WO2002062803A1 (fr) * | 2001-02-08 | 2002-08-15 | Yamanouchi Pharmaceutical Co., Ltd. | Derive de thienopyrimidine |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1470356A1 (de) * | 1964-01-15 | 1970-04-30 | Thomae Gmbh Dr K | Neue Thieno[3,2-d]pyrimidine und Verfahren zu ihrer Herstellung |
DE2032687A1 (en) * | 1970-07-02 | 1972-01-05 | Dr. Karl Thomae Gmbh, 7950 Biberach | Cardiovascular 2-aminoalkylamino-thienopyrimidines - and 4-morpholino derivatives from 4-diethanolamino-compounds by intramolecular cyclisa |
DE2058086A1 (de) * | 1970-11-26 | 1972-05-31 | Thomae Gmbh Dr K | Neue 4-Morpholino-thieno[3,2-d]pyrimidine,deren Salze und Verfahren zur Herstellung |
DE2137341A1 (de) * | 1971-07-26 | 1973-02-15 | Thomae Gmbh Dr K | Neue thieno eckige klammer auf 3,2-d eckige klammer zu pyrimidine |
DE2200764A1 (de) * | 1972-01-07 | 1973-07-12 | Thomae Gmbh Dr K | Neue thieno eckige klammer aff 2,3-d eckige klammer zu pyrimidine und verfahren zu ihrer herstellung |
JPH03148265A (ja) * | 1989-11-01 | 1991-06-25 | Sumitomo Chem Co Ltd | 5,7―ジフェニル―4,6―ジアザインダン誘導体、その製造法およびそれを有効成分とする除草剤 |
DE4008726A1 (de) * | 1990-03-19 | 1991-09-26 | Basf Ag | Thieno(2,3-d)pyrimidinderivate |
JP2817863B2 (ja) * | 1992-02-21 | 1998-10-30 | 宇部興産株式会社 | 含フッ素ピラゾール化合物、その製法及び有害生物防除剤 |
EP0791000B1 (en) * | 1994-11-08 | 2002-10-02 | Takeda Chemical Industries, Ltd. | Thienopyridine or thienopyrimidine derivatives and their use |
US5814308A (en) * | 1996-03-26 | 1998-09-29 | Zhang; Ke | Methods for the treatment of gastrointestinal tract disorders |
US6043066A (en) * | 1997-09-04 | 2000-03-28 | Mangano; Joseph A. | Cell separation using electric fields |
US6897220B2 (en) * | 2001-09-14 | 2005-05-24 | Methylgene, Inc. | Inhibitors of histone deacetylase |
WO2003038055A2 (en) * | 2001-10-31 | 2003-05-08 | Mds Proteomics, Inc. | Proteins involved in regulation of adipocytes and uses related thereto |
AU2003251954B2 (en) * | 2002-07-19 | 2008-06-26 | University Of North Carolina At Chapel Hill | Method of obtaining viable human liver cells, including hepatic stem/progenitor cells |
-
2003
- 2003-09-25 AR ARP030103503A patent/AR044743A1/es unknown
- 2003-09-25 TW TW092126472A patent/TW200410975A/zh unknown
- 2003-09-26 US US10/529,474 patent/US20070010402A1/en not_active Abandoned
- 2003-09-26 AU AU2003272898A patent/AU2003272898B2/en not_active Expired - Fee Related
- 2003-09-26 WO PCT/JP2003/012356 patent/WO2004029060A1/ja active Application Filing
- 2003-09-26 EP EP03753959A patent/EP1544202A4/en not_active Withdrawn
- 2003-09-26 CA CA002500207A patent/CA2500207A1/en not_active Abandoned
Patent Citations (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1570494A (en) * | 1975-11-28 | 1980-07-02 | Ici Ltd | Thienopyrimidine derivatives and their use as pesticides |
US4196207A (en) * | 1977-05-23 | 1980-04-01 | Ici Australia Limited | Process for controlling eradicating or preventing infestations of animals by Ixodid ticks |
EP0082023A2 (en) * | 1981-12-16 | 1983-06-22 | Sankyo Company Limited | Thienopyrimidine derivatives, their preparation and their medical use |
EP0202538A1 (de) * | 1985-05-17 | 1986-11-26 | Bayer Ag | Leistungsfördernde Mittel |
EP0404356A1 (en) * | 1989-05-30 | 1990-12-27 | Smithkline Beecham Intercredit B.V. | Substituted thienopyrimidine derivatives, their preparation, pharmaceutical compositions and medical use |
JPH0578721A (ja) * | 1991-09-19 | 1993-03-30 | Nippon Steel Corp | 溶融還元の操業方法 |
WO1993017021A1 (en) * | 1992-02-19 | 1993-09-02 | Pfizer, Inc. | Heterocyclic compounds for enhancing antitumor activity |
EP0579424A1 (en) * | 1992-07-17 | 1994-01-19 | Rohm And Haas Company | 2-substituted pyrimidines and herbicidal use thereof |
WO1994008975A1 (en) * | 1992-10-16 | 1994-04-28 | Nippon Soda Co., Ltd. | Pyrimidine derivative |
WO1998006722A1 (de) * | 1996-08-12 | 1998-02-19 | Merck Patent Gmbh | Thienopyrimidine |
WO1998017668A1 (de) * | 1996-10-24 | 1998-04-30 | Merck Patent Gmbh | Thienopyrimidine mit pde v inhibierender wirkung |
EP0899263A2 (en) * | 1997-08-13 | 1999-03-03 | Fujirebio Inc. | Fused pyrimidine derivatives and medicaments thereof for a blood oxygen partial pressure amelioration |
WO2000027812A1 (de) * | 1998-11-11 | 2000-05-18 | Bayer Aktiengesellschaft | Phenyl-substituierte zyklische enaminone |
US6133271A (en) * | 1998-11-19 | 2000-10-17 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives |
US5948911A (en) * | 1998-11-20 | 1999-09-07 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure to thienopyrimidine derivatives |
WO2001002409A1 (en) * | 1999-07-01 | 2001-01-11 | Vernalis Research Limited | Thieno- and furopyrimidine derivatives as a2a-receptor antagonists |
WO2001032632A2 (en) * | 1999-11-01 | 2001-05-10 | Eli Lilly And Company | Pharmaceutically active 4-substituted pyrimidine derivatives |
WO2001040202A1 (de) * | 1999-12-02 | 2001-06-07 | Bayer Aktiengesellschaft | (hetero)aryl-substituierte heterozyklische enaminone, deren herstellung und deren verwendung als herbizide, akarizide und insektizide |
WO2002062803A1 (fr) * | 2001-02-08 | 2002-08-15 | Yamanouchi Pharmaceutical Co., Ltd. | Derive de thienopyrimidine |
Non-Patent Citations (7)
Title |
---|
IFE, R.J ET AL.: "Reversible inhibitors of the Gastric (H+/K+)-ATPase. 5. Substituted 2,4-Diaminoquinazolines and Thienopyrimidines.", J. MED. CHEM., vol. 38, 1995, pages 2763 - 2773, XP002121213 * |
KOUROUNAKIS, A.P. ET AL.: "Elucidation of Structure-Activity Relations of 2-Amino-3-benzoylthiophenes:Study of Their Allosteric Enchancing vs. Antagonistic Activity on Adenosine A1, Receptors.", DRUG DEVELOPMENT RESEARCH, vol. 49, no. 4, 2000, pages 227 - 237, XP002974953 * |
RAM, V.J. ET AL.: "Thieno[2,3-d]pyrimidines as potential Chemotherapeutic Agents II.", J. HETEROCYCLIC MED., vol. 18, no. 7, November 1981 (1981-11-01), pages 1277 - 1280, XP002974952 * |
See also references of EP1544202A4 * |
TAKAHASHI, A ET AL.: "Mitotic disruption by a novel pyrimidine herbicide, NS-245852, in oat (Avena sativa L.) roots.", WEED BIOLOGY AND MANAGEMENT, vol. 1, no. 3, 23 January 2001 (2001-01-23), pages 182 - 188, XP002974949 * |
TANAKA, K ET AL.: "Synthesis and herbicidal activity of pyrimidine derivatives.", PESTICIDE SCIENCE, vol. 55, no. 3, 1999, pages 370 - 372, XP002974950 * |
YAMAGUCHI, H ET AL.: "Synthesis and Reactions of 2-Chloro-3,4-dihydrothienopyrimidines and-quinazolines.", JOURNAL HETEROCYCLIC CHEM., vol. 18, January 1981 (1981-01-01), pages 67 - 70, XP002974951 * |
Cited By (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7071190B2 (en) | 2002-02-15 | 2006-07-04 | Rigel Pharmaceuticals, Inc. | Inhibitors to tubulin polymerization |
US7601725B2 (en) | 2004-07-16 | 2009-10-13 | Sunesis Pharmaceuticals, Inc. | Thienopyrimidines useful as Aurora kinase inhibitors |
WO2006046485A1 (ja) * | 2004-10-25 | 2006-05-04 | Nihon Nohyaku Co., Ltd. | 畑作用除草剤組成物及び防除方法 |
US8841323B2 (en) | 2006-03-15 | 2014-09-23 | Janssen Pharmaceuticals, Inc. | 1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors |
US9266834B2 (en) | 2006-03-15 | 2016-02-23 | Janssen Pharmaceuticals, Inc. | 1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors |
US9067891B2 (en) | 2007-03-07 | 2015-06-30 | Janssen Pharmaceuticals, Inc. | 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mGluR2-receptors |
US8906939B2 (en) | 2007-03-07 | 2014-12-09 | Janssen Pharmaceuticals, Inc. | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
US11071729B2 (en) | 2007-09-14 | 2021-07-27 | Addex Pharmaceuticals S.A. | 1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′]bipyridinyl-2′-ones |
US9114138B2 (en) | 2007-09-14 | 2015-08-25 | Janssen Pharmaceuticals, Inc. | 1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′] bipyridinyl-2′-ones |
US9132122B2 (en) | 2007-09-14 | 2015-09-15 | Janssen Pharmaceuticals, Inc. | 1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′]bipyridinyl-2′-ones |
US8722894B2 (en) | 2007-09-14 | 2014-05-13 | Janssen Pharmaceuticals, Inc. | 1,3-disubstituted-4-phenyl-1H-pyridin-2-ones |
US8748621B2 (en) | 2007-09-14 | 2014-06-10 | Janssen Pharmaceuticals, Inc. | 1,3-disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones |
US10888579B2 (en) | 2007-11-07 | 2021-01-12 | Beeologics Inc. | Compositions for conferring tolerance to viral disease in social insects, and the use thereof |
US8785486B2 (en) | 2007-11-14 | 2014-07-22 | Janssen Pharmaceuticals, Inc. | Imidazo[1,2-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
US8691849B2 (en) | 2008-09-02 | 2014-04-08 | Janssen Pharmaceuticals, Inc. | 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors |
US8697689B2 (en) | 2008-10-16 | 2014-04-15 | Janssen Pharmaceuticals, Inc. | Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors |
US8691813B2 (en) | 2008-11-28 | 2014-04-08 | Janssen Pharmaceuticals, Inc. | Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors |
US8946205B2 (en) | 2009-05-12 | 2015-02-03 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
US9737533B2 (en) | 2009-05-12 | 2017-08-22 | Janssen Pharmaceuticals. Inc. | 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders |
US8937060B2 (en) | 2009-05-12 | 2015-01-20 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders |
US9085577B2 (en) | 2009-05-12 | 2015-07-21 | Janssen Pharmaceuticals, Inc. | 7-aryl-1,2,4-triazolo[4,3-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
US10071095B2 (en) | 2009-05-12 | 2018-09-11 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of neurological and psychiatric disorders |
US9226930B2 (en) | 2009-05-12 | 2016-01-05 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders |
US10801028B2 (en) | 2009-10-14 | 2020-10-13 | Beeologics Inc. | Compositions for controlling Varroa mites in bees |
US9988634B2 (en) | 2010-03-08 | 2018-06-05 | Monsanto Technology Llc | Polynucleotide molecules for gene regulation in plants |
US9121022B2 (en) | 2010-03-08 | 2015-09-01 | Monsanto Technology Llc | Method for controlling herbicide-resistant plants |
US11812738B2 (en) | 2010-03-08 | 2023-11-14 | Monsanto Technology Llc | Polynucleotide molecules for gene regulation in plants |
US9012448B2 (en) | 2010-11-08 | 2015-04-21 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors |
US8993591B2 (en) | 2010-11-08 | 2015-03-31 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors |
US9271967B2 (en) | 2010-11-08 | 2016-03-01 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
EP3382027A2 (en) | 2011-09-13 | 2018-10-03 | Monsanto Technology LLC | Methods and compositions for weed control |
US9422558B2 (en) | 2011-09-13 | 2016-08-23 | Monsanto Technology Llc | Methods and compositions for weed control |
EP3434780A1 (en) | 2011-09-13 | 2019-01-30 | Monsanto Technology LLC | Methods and compositions for weed control |
WO2013039990A1 (en) | 2011-09-13 | 2013-03-21 | Monsanto Technology Llc | Methods and compositions for weed control |
US10808249B2 (en) | 2011-09-13 | 2020-10-20 | Monsanto Technology Llc | Methods and compositions for weed control |
US10760086B2 (en) | 2011-09-13 | 2020-09-01 | Monsanto Technology Llc | Methods and compositions for weed control |
WO2013040117A1 (en) | 2011-09-13 | 2013-03-21 | Monsanto Technology Llc | Methods and compositions for weed control |
US10829828B2 (en) | 2011-09-13 | 2020-11-10 | Monsanto Technology Llc | Methods and compositions for weed control |
EP3296402A2 (en) | 2011-09-13 | 2018-03-21 | Monsanto Technology LLC | Methods and compositions for weed control |
US9422557B2 (en) | 2011-09-13 | 2016-08-23 | Monsanto Technology Llc | Methods and compositions for weed control |
WO2013040021A1 (en) | 2011-09-13 | 2013-03-21 | Monsanto Technology Llc | Methods and compositions for weed control |
EP3434779A1 (en) | 2011-09-13 | 2019-01-30 | Monsanto Technology LLC | Methods and compositions for weed control |
US10806146B2 (en) | 2011-09-13 | 2020-10-20 | Monsanto Technology Llc | Methods and compositions for weed control |
US9416363B2 (en) | 2011-09-13 | 2016-08-16 | Monsanto Technology Llc | Methods and compositions for weed control |
US9604994B2 (en) | 2011-11-23 | 2017-03-28 | Cancer Research Technology Limited | Thienopyrimidine inhibitors of atypical protein kinase C |
US10954251B2 (en) | 2011-11-23 | 2021-03-23 | Cancer Research Technology Limited | Thienopyrimidine inhibitors of atypical protein kinase C |
US10183950B2 (en) | 2011-11-23 | 2019-01-22 | Cancer Research Technology Limited | Thienopyrimidine inhibitors of atypical protein kinase C |
US10240162B2 (en) | 2012-05-24 | 2019-03-26 | A.B. Seeds Ltd. | Compositions and methods for silencing gene expression |
US10240161B2 (en) | 2012-05-24 | 2019-03-26 | A.B. Seeds Ltd. | Compositions and methods for silencing gene expression |
US10934555B2 (en) | 2012-05-24 | 2021-03-02 | Monsanto Technology Llc | Compositions and methods for silencing gene expression |
US10041068B2 (en) | 2013-01-01 | 2018-08-07 | A. B. Seeds Ltd. | Isolated dsRNA molecules and methods of using same for silencing target molecules of interest |
US10683505B2 (en) | 2013-01-01 | 2020-06-16 | Monsanto Technology Llc | Methods of introducing dsRNA to plant seeds for modulating gene expression |
US10612019B2 (en) | 2013-03-13 | 2020-04-07 | Monsanto Technology Llc | Methods and compositions for weed control |
US10609930B2 (en) | 2013-03-13 | 2020-04-07 | Monsanto Technology Llc | Methods and compositions for weed control |
WO2014151255A1 (en) | 2013-03-15 | 2014-09-25 | Monsanto Technology Llc | Methods and compositions for weed control |
US10568328B2 (en) | 2013-03-15 | 2020-02-25 | Monsanto Technology Llc | Methods and compositions for weed control |
US10584129B2 (en) | 2013-06-04 | 2020-03-10 | Janssen Pharmaceuticals Nv | Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of mGluR2 receptors |
US10106542B2 (en) | 2013-06-04 | 2018-10-23 | Janssen Pharmaceutica Nv | Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of mGluR2 receptors |
US10597676B2 (en) | 2013-07-19 | 2020-03-24 | Monsanto Technology Llc | Compositions and methods for controlling Leptinotarsa |
US9856495B2 (en) | 2013-07-19 | 2018-01-02 | Monsanto Technology Llc | Compositions and methods for controlling Leptinotarsa |
US9850496B2 (en) | 2013-07-19 | 2017-12-26 | Monsanto Technology Llc | Compositions and methods for controlling Leptinotarsa |
US9777288B2 (en) | 2013-07-19 | 2017-10-03 | Monsanto Technology Llc | Compositions and methods for controlling leptinotarsa |
US11377667B2 (en) | 2013-07-19 | 2022-07-05 | Monsanto Technology Llc | Compositions and methods for controlling Leptinotarsa |
US9708315B2 (en) | 2013-09-06 | 2017-07-18 | Janssen Pharmaceutica Nv | 1,2,4-triazolo[4,3-a]pyridine compounds and their use as positive allosteric modulators of MGLUR2 receptors |
US10927374B2 (en) | 2013-11-04 | 2021-02-23 | Monsanto Technology Llc | Compositions and methods for controlling arthropod parasite and pest infestations |
US9540642B2 (en) | 2013-11-04 | 2017-01-10 | The United States Of America, As Represented By The Secretary Of Agriculture | Compositions and methods for controlling arthropod parasite and pest infestations |
US10100306B2 (en) | 2013-11-04 | 2018-10-16 | Monsanto Technology Llc | Compositions and methods for controlling arthropod parasite and pest infestations |
US10557138B2 (en) | 2013-12-10 | 2020-02-11 | Beeologics, Inc. | Compositions and methods for virus control in Varroa mite and bees |
US10334848B2 (en) | 2014-01-15 | 2019-07-02 | Monsanto Technology Llc | Methods and compositions for weed control using EPSPS polynucleotides |
WO2015108982A2 (en) | 2014-01-15 | 2015-07-23 | Monsanto Technology Llc | Methods and compositions for weed control using epsps polynucleotides |
US11369606B2 (en) | 2014-01-21 | 2022-06-28 | Janssen Pharmaceutica Nv | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
US11103506B2 (en) | 2014-01-21 | 2021-08-31 | Janssen Pharmaceutica Nv | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
US10537573B2 (en) | 2014-01-21 | 2020-01-21 | Janssen Pharmaceutica Nv | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
US12048696B2 (en) | 2014-01-21 | 2024-07-30 | Janssen Pharmaceutica Nv | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
US11091770B2 (en) | 2014-04-01 | 2021-08-17 | Monsanto Technology Llc | Compositions and methods for controlling insect pests |
US10988764B2 (en) | 2014-06-23 | 2021-04-27 | Monsanto Technology Llc | Compositions and methods for regulating gene expression via RNA interference |
US11807857B2 (en) | 2014-06-25 | 2023-11-07 | Monsanto Technology Llc | Methods and compositions for delivering nucleic acids to plant cells and regulating gene expression |
US10378012B2 (en) | 2014-07-29 | 2019-08-13 | Monsanto Technology Llc | Compositions and methods for controlling insect pests |
US11124792B2 (en) | 2014-07-29 | 2021-09-21 | Monsanto Technology Llc | Compositions and methods for controlling insect pests |
US10968449B2 (en) | 2015-01-22 | 2021-04-06 | Monsanto Technology Llc | Compositions and methods for controlling Leptinotarsa |
US10883103B2 (en) | 2015-06-02 | 2021-01-05 | Monsanto Technology Llc | Compositions and methods for delivery of a polynucleotide into a plant |
US10655136B2 (en) | 2015-06-03 | 2020-05-19 | Monsanto Technology Llc | Methods and compositions for introducing nucleic acids into plants |
Also Published As
Publication number | Publication date |
---|---|
CA2500207A1 (en) | 2004-04-08 |
TW200410975A (en) | 2004-07-01 |
EP1544202A4 (en) | 2007-07-18 |
US20070010402A1 (en) | 2007-01-11 |
AU2003272898B2 (en) | 2009-08-13 |
AU2003272898A1 (en) | 2004-04-19 |
EP1544202A1 (en) | 2005-06-22 |
AR044743A1 (es) | 2005-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004029060A1 (ja) | 新規除草剤、その使用方法、新規チエノピリミジン誘導体及びその中間体並びにその製造方法 | |
JP3290178B2 (ja) | スルホンアミド除草剤 | |
JP2598540B2 (ja) | アルコキシ‐1,2,4‐トリアゾロ〔1,5‐c〕ピリミジン‐2‐スルホンアミド,その製造法及び中間体 | |
KR100488277B1 (ko) | N-([1,2,4]트리아졸로아지닐)벤젠설폰아미드및피리딘설폰아미드화합물,및이들을함유하는제초제조성물 | |
KR890000728B1 (ko) | 피라졸술포닐우레아 유도체의 제조방법 | |
JP2009137851A (ja) | 2−トリフルオロメチルピリミジン−6(1h)−オン誘導体及びその製造方法並びに該誘導体を有効成分として含有する除草剤 | |
JP2009126792A (ja) | 5−置換フェニル−2−トリフルオロメチルピリミジン−6(1h)−オン誘導体及びその製造方法並びに該誘導体を有効成分として含有する除草剤 | |
JP4327258B2 (ja) | シクロイミド置換ベンゾ縮合ヘテロ環状除草剤 | |
JP2002205992A (ja) | 二環式トリアゾロン誘導体およびそれを含有する除草剤 | |
JP2002205986A (ja) | ピリミジン誘導体およびそれを含有する除草剤 | |
KR20040004427A (ko) | 제초제로서의 ν-([1,2,4]트리아졸로아지닐)티오펜설폰아미드 화합물 | |
JP4297226B2 (ja) | アニリノピリミジノン誘導体、それらの製造方法及びそれらを有効成分として含有する殺虫、殺ダニ剤 | |
JP2946656B2 (ja) | ウラシル誘導体および除草剤 | |
JP2817863B2 (ja) | 含フッ素ピラゾール化合物、その製法及び有害生物防除剤 | |
JPWO2019168112A1 (ja) | イミド誘導体およびそれらを有効成分として含有する殺菌剤 | |
JP3355237B2 (ja) | N−(置換アミノ)ピロール誘導体、その製造方法及び除草剤 | |
JP4674676B2 (ja) | 2−置換アミノピリミジノン誘導体、それらの製造方法並びにそれらを有効成分とする殺虫、殺ダニ剤 | |
JP2004137270A (ja) | 新規除草剤、その使用方法、新規置換チエノピリミジン誘導体及びその中間体並びにそれらの製造方法 | |
JPH0641116A (ja) | ピリジン誘導体及び除草剤 | |
WO2001010843A1 (fr) | Derives de 4-(phenyl substitue)-5-halopyrimidine et herbicides contenant ces derives comme ingredients actifs | |
JPH11180964A (ja) | 1,2,4−トリアジン−3,5− ジオン類、およびこれを有効成分とする除草剤 | |
JP2001106675A (ja) | 4−置換フェニル−5−ハロピリミジン誘導体及びこれを有効成分とする除草剤 | |
JPS59219281A (ja) | ピラゾ−ルスルホニルウレア誘導体、その製法および該誘導体を含有する選択性除草剤 | |
JP2003212859A (ja) | 置換フェニルヘテロ環類及びこれを有効成分とする除草剤 | |
CN119059986A (zh) | 含稠杂酮的苯甲酰胺类化合物及其制备方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2500207 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003753959 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003272898 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2003753959 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007010402 Country of ref document: US Ref document number: 10529474 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 10529474 Country of ref document: US |